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ABSTRACT
A self-medication theoiy of substance abuse has been proposed to account for
high prevalence of cigarette smoking in adults with attention-deficit hyperactivity
disorder (ADHD). It has been suggested that in smokers with ADHD nicotine might
attenuate some of the symptoms of the disorder, especially inattentiveness. Animal
research and human studies using non-ADHD smokers and non-smokers have
produced mixed evidence on the cognitive effects of nicotine with the most consistent
finding of improved sustained attention in a variety of vigilance tasks. Few existing
studies examining the effects of nicotine in ADHD adults have provided further
support to the hypothesis of ameliorating effects of nicotine on sustained attention.
The present study was conducted to evaluate whether adult non-smokers with low
attentiveness might exhibit greater sensitivity to nicotine and consequently greater
improvement on measures of attention and working memory than those with higher
attentiveness using neuropsychological tests that had previously shown usefulness in
the diagnosis of ADHD.
In accordance with their attention scores on the Current Symptoms Scale by
Barkley and Murphy and Self-Report Rating Scale by McCamey and Anderson, 62
male non-smokers were assigned to either low (possible problems of inattentiveness)
or high (few or no attentional difficulties) attention groups. Each participant was
treated with either a placebo or a 7mg- of- nicotine transdermal patches. Six hours
after the application of a patch, participants were individually administered the

Wisconsin Card Sorting Test, classic Stroop task, and Conner's Continuous
Performance Test (CPT) in a counterbalanced order. The results did not show
performance differences on the Stroop task. On the Conner's CPT nicotine reduced
the number of errors of commission, improved stimulus detectability and reduced the
number of perseverations irrespective of the attentional group status. On the
Wisconsin Card Sorting test nicotine significantly impaired the ability of non-smokers
in the high attention group to learn effective strategies to complete the test with fewer
trials. The results suggested nicotine-induced improvement on some measures of
sustained attention. Overall, the study did not produce conclusive evidence of
cognitive effects of nicotine possibly due to the lack of tolerance in non-smokers to
the adverse physiological effects of nicotine.

IX

CHAPTER 1
INTRODUCTION
ADHD in Adults
Diagnosis
Despite a considerable number of publications devoted to childhood attentiondeficit hyperactivity disorder (ADHD), which has been estimated to affect 6 to 9 % of
school-aged children, in adults the disorder has been recognized only recently as it
was believed that ADHD symptoms remit during childhood (Barkley, 1998).
Nevertheless, extant evidence suggests that the disorder persists into adulthood in as
many as 80% of the childhood ADHD cases (Murphy and Gordon, 1996).
According to the fourth edition of the Diagnostic and Statistical Manual for
Mental Disorders (DSM-IV, 1994) Attention-Deficit/Hyperactivity Disorder (ADHD)
is characterized by three core symptoms of inattention (inability to focus on tasks,
easy distractability, loss of things, difficulty in organization and priority setting,
inconsistency in work performance) hyperactivity (restless, fidgety, impatient) and
impulsivity (acting out, driving tickets, verbal faux pas, a pattern of impulsive acts,
mood swings, low frustration tolerance, ready anger). Depending upon the degree of
symptomatic expression three types of the disorder are recognized under the DSM -IV
criteria: combined type, predominantly inattentive type, and predominately
hyperactive-impulsive type. Other non-diagnostic symptoms include procrastination,
a sense of failure, low self-esteem and impairment of social skills (Weiss et al., 1999).
While it was originally assumed that ADHD was primarily a disorder of
attention, nowadays it is believed to stem from a developmental failure in the brain
1
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circuitry that underlies inhibition and self-control (Barkley, 1998). For example, it has
been demonstrated that children with ADHD do not show an inability to filter
competing sensory inputs, such as sights and sounds as was formerly believed by the
proponents of the attention hypothesis (Barkley, 1998). Instead it has been suggested
that children with ADHD have difficulty inhibiting ‘heir impulsive motor response to
such input and are less capable of anticipating events and preparing appropriate motor
responses (Barkley, 1998).
It has been noted, however, that over the course of a child's development the
core features of ADHD (inattention, impulsivity and h^rperactivity) can change in both
quantity and quality, stay the same or disappear in adulthood (Weiss & Hechtman,
1993). Developmental change in the above features has been proposed as one of the
reasons why ADHD in adults has not been recognized until the late 80s. Specifically,
the failure to recognize the adult form of ADHD is related to a decrease in the most
visible and disruptive symptom of hyperactivity with age (Murphy & Gordon, 1996).
Impulsivity has been reported to assume a different quality while attention problems
generally persist unchanged but could become more disabling if organizational
demands increase (Weiss, & Hechtman, 1993). In a study by Millstein, Wilens, and
Biederman (1997) 93 percent of 149 adults with ADHD reported symptoms of
inattention either alone or with hyperactivity-impulsivity. On the other hand only 2
percent reported symptoms of hyperactivity-impulsivity in the absence of attention
problems.
Another problem in diagnosing ADHD in adults stems from the difficulty to
establish accurate diagnostic criteria since its symptoms are also characteristic of a
number of other psychiatric disorders such as Generalized Anxiety Disorder,
Borderline Personality Disorder, depression, Obsessive Compulsive Disorder etc.,
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which can also become comorbid conditions to the existing ADHD (Weiss &
Hechtman, 1993). Additionally, the core ADHD features of inattent'veness,
impulsivity and hyperactivity are not found exclusively in disabled individuals but are
characteristic of the general population, which exhibits these symptoms to a lesser
degree. Therefore, recognition of a clinically significant intensity cf a particular
symptom is often a difficult decision on the part of the diagnostician.
Evaluation for adult ADHD involves several steps. The assessment is initiated
in an interview during which answers are obtained to four fundamental diagnostic
questions. The first question is meant to establish childhood history of ADHD that led
to substantial and chronic impairments across settings, which according to the DSMIV criteria should be present before age 7. This information is usually obtained from
the retrospective account of the adult participant by administering a Wender Utah
Rating Scale (WURS) (Ward et al., 1993), which has been found to correctly identify
86% of adults with ADHD, 99% of normal participants, and 81% of adults with major
depression. The scale emphasizes more observable symptoms of hyperactivity and
impulsivity rather than quiet inattentiveness. Sixty-one items of the scale are rated
along five measures of the degree of symptom expression (not at all/or very slightly,
mildly, moderately, quite a bit, very much).
Another common self-report tool that has been used to identify ADHD-related
problems in childhood is the Childhood Symptoms Scale (Barkley & Murphy, 1998),
which unlike the Wender Utah Rating Scale gives equal emphasis to problems with
inattentiveness. The scale contains 18 symptom items for ADHD from DSM-IV
arranged in such a way that items pertaining to inattention are odd-numbered and
those pertaining to hyperactive-impulsive symptoms are even-numbered. The items
are rated on a four-point scale (from 0 to 3) with zero indicating 'never or rarely', three

4

meaning 'very often' and one and two being 'sometimes' and 'often', respectively. The
scale also contains questions regarding the age of onset of symptoms and areas in
which the client believes that any of the listed problems interfered with his/her ability
to function between ages 5 and 12. Additionally, the scale provides items taken from
DSM-IV for Oppositional Defiant Disorder (ODD), some elements of which along
with symptoms of ADHD have been found to continue into adulthood and contribute
to impairment in interpersonal relations and employment (Barkley and Murphy,
1998). Whenever possible adults are encouraged to provide hard evidence of their
childhood problems in the form of test reports, teachers' comments and academic
records. Input from people close to the patient (especially from his/her parent) also
contributes to the accuracy of the assessment.
The second question pertains to the presence of ADHD-type symptoms that
currently cause the patient substantial and consistent impairment across settings. To
identify the presence of ADHD symptoms DSM-IV criteria are used differentiating
between the three types of the disorder. The level of impairment is determined during
the interview along such dimensions as quality of life, family life, work, love,
education and activities of daily living (Weiss, Hechtmann, and Weiss, 1999).
Impairment is normally assessed both relative to expected social norms and to one's
individual potential. Underachievement relative to one's individual potential but at a
level of performance higher than that expected under a social norm is not considered
sufficient to exclude impairment (Weiss et al., 1999). A self-report version rating
form by McCamey and Anderson (1996) is sometimes used to identify the adults'
subtype of the disorder. This instrument contains two sections with the first subscale
listing 31 items pertaining to inattention, and the second subscale assessing the
presence of the symptoms of the hyperactive-impulsive subtype comprising 27
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questions. Both sections are rated on a 5-point scale with zero being 'do not engage in
the behavior' and four indicating 'one to several times per hour' (values one through
three evaluate singular or multiple occurrence of symptoms on a monthly, weekly,
and daily basis, respectively).
A self-report scale by Barkley and Murphy (1998) is also used to assess
current ADHD symptomatology for the past 6 months in combination with their
Childhood Symptoms Scale. The Current Symptoms Scale is constructed similarly to
its childhood version listing 18 items from DSM-IV pertaining to currently
experienced symptoms of ADHD, identifying areas of impairment and inquiring
about occurrence of the ODD symptoms such as lost temper, defiance, vindictiveness
etc.
Screening for the presence of ODD helps to answer another important
diagnostic question during the assessment for ADHD, which considers other possible
explanations for the existing clinical picture. This is done to ensure that the presented
symptoms are not expressions of other medical conditions such as hypo-and
hyperthyroidism, diabetes, certain heart problems, psychiatric disorders, personality
disorder, learning problem, or situational stressor. For this purpose clinicians often
administer the Structured Clinical Interview for DSM-IV (SCID), which surveys all
major Axis I diagnoses.
Finally, if ADHD cannot be ruled out the existence of possible comorbid
conditions is evaluated. Comorbidity of ADHD with other psychiatric disorders has
been found to be as high as 77 percent (Biederman et al, 1995) with affective
disorders, anxiety disorders, personality disorders and substance abuse being the most
common comorbid conditions in adulthood (Weiss et al., 1999). There are several
standardized and widely circulated instruments available for the identification of
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comorbid conditions that include the Symptom Checklist (SCL-90, Derogatis, 1983),
Hamilton Rating Scale for Depression (HRSD, Hamilton, 1960) or Beck Depression
Inventory (BDI, Beck, 1965).
Neuropsychological Assessment
Accurate assessment of adult ADHD has been shown to profit from
neuropshychological and computerized tests of attention and inhibitory skills (Weiss
et al, 1999). One of such tests, the Continuous Performance Test (CPT, Rosvold et al.,
1956) been found useful in differentiating a child with ADHD from a normal child. Its
accuracy rate of identification has been reported to approximate 70 percent in the age
range of 6 to 17 (Weiss et al., 1999). Although not diagnostic in itself the CPT has
been suggested as an important diagnostic supplement in both pediatric as well adult
evaluations (Greenhill et al., 1996). On this task motor inhibition is measured as a
number of errors of commission/omission in response to the target stimulus. It has
been argued, however, that task parameters and response outcome measures can
markedly affect performance on the CPT of individuals with ADHD (Epstein et al.,
1998). In this regard traditional CPT tasks have been considered inadequate in
assessing motor and attention deficits in the ADHD population (Schachar et al.,
1988). In the traditional CPT participants are required to press a computer key in
response to the presentation of consecutive target letters (e.g., "A" followed by "X")
at the interval (ISI) between 600 ms and 1.5 s. Typically target letter combinations
constitute only 10% of all two-letter combinations. A low response rate, therefore, is
more appropriate for the evaluation of signal detection rather than motor inhibition,
since most of the time the participant is not making any overt response (Schachar et
al., 1990).
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A modified version has been proposed hv Conners (1994). In this
nontraditional task participants are asked to respond to every stimulus except the
target letter combination, which provides a better measure of impulsive response
styles, allows for a more reliable assessment of reaction times to a larger response
sample, increases the likelihood of errors of commission. Conners (1994) also
suggested extending the interstimulus interval over 1.5 s, since children with ADHD
typically produce more attentional and impulsive errors during longer ISI (Epstein et
al., 1998).
Epstein et al. (1998) used the Conners CPT to compare 60 adults with ADHD
(34 males and 26 females) to 72 normal participants (42 males and 30 females). On
this 14-minute test the participants were instructed to press a keyboard spacebar as
quickly as possible in response to any letter except the letter "X" (probability of
occurrence = 0.90) but to refrain from responding every time the letter "X" (p =0.10)
appeared on the screen. Each letter appeared for 250 milliseconds over 18 blocks of
20 trials. The signal in each block was presented at one of the three interval rates, i.e.
1, 2, or 4 seconds in a counterbalanced order. The researchers measured reaction time,
accuracy, signal detection parameters of d' (sensitivity) and Beta (response bias) as
well as response variability between and within the blocks. The researchers found
that the participants with ADHD made significantly more errors of commission and
omission and showed a decrease in the stimulus sensitivity (lower d'). The ADHD
participants also showed faster reaction times than did normal controls (but the
difference was not statistically significant, p =0.06). No difference, however, was
found on the measure of intra-subject variability on reaction time throughout the task
(the standard error estimate of hit reaction time).
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The latter finding somewhat contradicted a contention that ADHD individuals
should demonstrate decrements in performance over time, which would indicate a
sustained attention deficit (Van der Meere & Sergeant, 1988). Nevertheless, the
researchers concluded that in their study participants' performance on the Conners
CPT showed a more impulsive clinical presentation in view of the greater number of
errors of commission and faster reaction times. Omission errors occurred mostly in
the first block of trials indicating increased difficulty of adults with ADHD adjusting
to the task directions or parameters. The researchers also noted that the Conners CPT
used in their study was only sensitive to about half of the cases of ADHD assessed in
the study while the other half of the ADHD adults in the sample performed in the
range of scores of the normal controls. Consequently, they suggested that normal
performance on the CPT should not be used to rule out the disorder while abnormal
scores could be indicative of ADHD.
It has been suggested that other neuropsychological measures could be more
sensitive to ADHD than the CPT since it has been demonstrated that the performance
on the CPT seems to improve with age and stimulant medication (Seidman et al,
1997). For example, in a study by Seidman et al. (1997) older male adolescents and
young adults with ADHD (ages 15-22, n=53) were compared to a sample of younger
male children (ages 9-14 years, n=65) with ADHD and to normal male controls of
corresponding age groups (n=58, and 41, respectively) on a variety of
neuropsychological measures. Differences in performance related to ADHD were
found on the auditory CPT (Weintraub & Mesulam, 1985), the Rey-Osterrieth
Complex Figure Copy (ROCF, Osterrieth, 1944;) the Wisconsin Card Sorting Test
(WCST; Heaton et al. 1993) and the classic Stroop test (Golden, 1978).

In the auditory CPT the participants are asked to press a hand-held button in
response to the lowest intensity tone (target, 67dB) presented at 500 HZ in a sequence
of three tones of different amplitude in random order with intervals of 2 seconds
between the tones. The task has been previously shown to produce cerebral metabolic
abnormalities in adults with ADHD compared to normal controls, as assessed by PET
scanning. The cerebral abnormalities were observed in the absence of any significant
differences on behavioral measures (errors of commission, omission, iate
responses)(Zametkin et al., 1990). The results indicated that performance on the CPT
(errors of omission) improved with age in both ADHD and non-ADHD individuals.
Nevertheless, high school and college -age participants with ADHD showed
significantly greater impairment on the measure of the response speed (greater
response latency) than their age-matched controls.
In the ROCF task visual perception and long-term memory are evaluated. A
participant is asked to manually copy a complex figure presented to him and then to
reproduce it from memory. In assessing performance on this measure Seidman et al.
(1997) used the Waber-Holmes (1985) scoring system, which is developmentally
sensitive to changing organizational deficits as opposed to simple visual spatial
deficits and includes four dependent measures: copy organization, copy accuracy,
incidental delay organization, incidental delay accuracy (Seidman et al., 1997).
Children with ADHD showed significant impairment on the organization of the copy
of the ROCF. A similar organizational impairment was observed in the older ADHD
sample (ages 15 -22).
The WCST is a test of the frontal lobe function involving planning. On this
task participants are given a pack of 60 cards each displaying one or more symbols
represented by one of four shapes (triangle, star, cross, or circle) in one of four colors
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(red, green, yellow, or blue). The participants are told to place cards one by one under
four sample cards but are not informed what sorting strategy to use. The
determination of whether a particular sorting strategy is correct is based on the
experimenter's initial verbal reinforcement of the placement of a card under a certain
category. Once the participant deduces a correct strategy and correctly places 10
consecutive cards the rule is changed again and the participant has to find the next
correct strategy. The WCST dependent measures include the number of trials
administered, trials to complete the first category (the number of trials to make 10
consecutive correct responses), total number of categories achieved, total
number/percentage correct, failure to maintain set (interruption of the correct sorting
strategy after five consecutive correct responses had been made), perseverative errors
/ responses (responses that would have been correct under the previous sorting rule),
and total errors. The results indicated approximately the same levels of impairment
for both ADHD younger children and older participants on measures of categories,
perseverative and nonperseverative erros. Their scores on these measures, however,
were significantly lower than those in the age-matched control groups.
In the classic Stroop task participants are asked to name the ink color of a
color word while ignoring its meaning. Each word is printed on a 10 X 10 stimulus
card (e.g. the word "RED" printed in green ink). In the compatible condition the color
denoted by the word coincides with the ink color, while in the incompatible condition
the ink color of the word is different from its meaning. Finally, in the control
condition solid color squares are substituted for words. The researchers also asked
participants to name one of the color words (e.g. red, blue, green or yellow) printed on
the card in light gray ink. The difference in the speed of response between the
incompatible color and control conditions is attributed to the Stroop interference
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(MacLeod, 1991). Response latencies were taken tor words, colors and color-word
combinations. Additionally, the researchers obtained an interference t score Both age
groups of ADHD participants showed significantly more impairment on the Stroop
word, color, and color-word scores. On the basis of the obtained findings the
researchers concluded that those children who carry ADHD into adulthood are more
likely to show impairment on the Stroop test, the WCST, and the ROCF.
These findings are especially robust in view of the fact that 68% of the ADHD
participants in the sample received some form of pharmacological treatment for the
disorder that included stimulants (methylphenidate, n= 48; dextroamphetamine, n=4;
pemoline, n=5), tricyclic antidepressants (desipramine, n=27; nortriptyline, n =10;
imipramine, n=2) or other psychotropic medications (n=32). The researchers,
therefore, suggested that the medication used for the treatment of ADHD in the
sample either did not sufficiently attenuate cognitive impairment that was still evident
with a number of neurophysiological tests, or it improved only some aspects of
cognitive functioning (e.g. CPT performance) but not others (ROCF, WCST, Stroop).
Additionally, the researchers suggested that the familial status of ADHD could
be associated with more pronounced neuropsychological deficits since in the study the
48 participants with the family history of the disorder were significantly more
impaired than their age matched non-familial ADHD counterparts on the WCST.
Specifically they showed more impairment on the variable of failure to maintain set,
categories and nonperseverative errors. The familial type of ADHD could, therefore,
have a stronger biological basis.
Etiology o f ADHD
Evidence in support of the heritability of ADHD indicates a 51% concordance
rate among monozygotic twins, a 33% rate in dizygotic twins and up to 50% of
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concordance among full sibling pairs (e.g. Goodman & Stevenson, 1989; Safer,
1973). Additionally, the risk of developing the disorder if at least one of the parents
has been diagnosed with ADHD is 6.6 times greater for girls and only 1.5 times
greater for boys in comparison to age-matched children with no familial history of
ADHD (Zametkin, et al., 1998). It has been suggested that male children could be
more susceptible to nongenetic factors that have been linked to ADHD such as
premature birth, maternal alcohol and tobacco use, exposure to high levels of lead in
early childhood and brain injuries, especially those that involve the prefrontal cortex.
However, nongenetic factors were found to account only 20 to 30 % of male cases of
ADHD (Barkley, 1998).
Several lines of research (structural and functional brain imaging, genetic
studies and molecular studies) have examined the biological basis for ADHD directly.
One of the convergent findings suggests abnormal production and utilization of
dopamine, a neurotransmitter used by neurons in the brain for modulation or
inhibition of neuronal activity primarily involved in emotion and movement (Barkley,
1998). Dopamine (DA) is secreted by neurons in several specific parts of the brain
that have been grouped into three distinct systems. The nigrostriatal dopaminergic
system includes cell bodies of neurons in the substantia nigra that project their axons
to the caudate nucleus and the putamen - collectively known as the neostriatum
(Kandel, 2000). The neostriatum is an important part of the basal ganglia that
anatomically, besides the neostriatum also includes globus pallidus, amygdala and
claustrum. The clinical definition of basal ganglia, however, excludes the latter two
structures but includes the substantia nigra and subthalamic nucleus (Kieman, 1998).
The basal ganglia are involved in the control of movement, and the degeneration of
the dopaminergic connections between the substantia nigra and the caudate nucleus is
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considered crucial in the etiology of Parkinson's disease (Kandel, 2000). The second
dopamine system, the mesolimbic system, is considered important in rewarding
effects of different stimuli, including drugs of abuse (Benowitz, 1996). It projects
from the ventral tegmental area (VTA) of the midbrain to the nucleus accumbens,
amygdala, and hippocampus. The cell bodies in the VTA also project their axons to
the prefrontal cortex forming the mesocortical dopamine system, which is involved in
working memory, planning, and problem-solving (Kandel, 2000).
Genes in the prefrontal cortex and basal ganglia have been implicated in
defective encoding of dopamine receptors and transporters in children with ADHD
(Barkley, 1998). Specifically, Cook et al. (1995) have found that ADHD children are
more likely to have a particular mutation in the dopamine transporter DAT1 (Cook,
1995). Similarly, a particular variant of the dopamine receptor gene (D4) has been
found more common among children with ADHD (LaHoste, 1996). Mutations in the
dopamine receptor gene can diminish receptor sensitivity to dopamine. On the other
hand, mutations in the dopamine transporter gene can produce overly effective
transporters that would start transporting dopamine from the synaptic cleft back into
the presynaptic neuron before it binds to its target receptors on a neighboring cell
(Barkley, 1998).
Structural (MRI) imaging research has also shown that the prefrontal cortex
and basal ganglia are significantly smaller than normal in children with ADHD
(Castellanos & Rapoport, 1996). Additionally, several studies using positron emission
tomography (PET) to image cerebral glucose metabolism in adults and adolescents
with ADHD have found a decrease in brain metabolism in basal ganglia (Ernst et al.,
1994; Matochik et al., 1994). The basal ganglia (particularly the caudate nucleus and
the globus pallidiis) help to terminate automatic responses to allow more careful
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assessment by the cortex, and to coordinate neurological input among various cortical
regions. At the same time the right prefrontal cortex is said to be involved in "editing"
of one's behavior, helping to stay focused while resisting distractions and developing
an awareness of self and time (Barkley, 1998).
More specific behavioral outcomes in ADHD have been linked to particular
neurotransmitter disregulation. For example, behavioral manifestations of abnormal
dopamine function have been observed in the form of hyperactivity, inattention, tics,
dyskinesia, and self-mutilation (Oades, 1987). Additionally, problems of inattention,
distractability and sleeping difficulties have been associated with an imbalance in
epinephrine formation and consequent disruption of the normal function of the locus
ceruleus neurons (Mefford and Potter, 1989). McCracken (1991) combined the
findings of the previous research and suggested that effective pharmacological
treatment of ADHD should increase release of dopamine in the frontal-striatal region
and increase adrenergic inhibition in the locus ceruleus.
Anti-ADHD Medication
Current pharmacotherapy of ADHD, although not curative, has been found
effective in improving motor, affective, attentional, social and personal aspects of life
in diagnosed individuals (Biederman, 1998). The most common line of treatment
involves the use of stimulants such as methylphenidate hydrochloride (Ritalin), damphetamine (Dexedrine), magnesium pemoline (Cylert). Stimulants are structurally
similar to endogenous catecholamines (epinephrine, norepinephrine, and dopamine).
These drugs are thought to produce both central and peripheral effects in the nervous
system by preventing reuptake of catecholamines into presynaptic r erve endings and
thus preventing their degradation by monoamine oxidase (MAO, Biederman, 1998).
For example, methylphenidate acts by inhibiting dopamine transporters, thus
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increasing dopamine availability for target receptors of neighboring neurons in the
brain (Barkley, 1998). Although it is by far the most studied and the most prescribed
ADHD medication, there is little evidence of differential response to other stimulants
besides instances of atypical response preferences (Biederman, 1998). The typical
starting dose for methylphenidate is 10 mg/day with subsequent dose increases until
desired effects are observed or adverse side effect become too debilitating. The
suggested total daily dose for methylph idate ranges from 0.3 mg/kg to 1.0-1.5
mg/kg after titration (Biederman, 1998). Both methylphenidate and d-amphitamine
(which is twice as potent as methylphenidate) are relatively short acting compounds
with the onset of action within 80 to 60 minutes (Biederman, 1998). A peak clinical
effect is normally seen between 1 and 8 hours after administration, which, therefore,
requires multiple daily intakes. Magnesium pemoline, however, is about 8 times less
potent than methylphenidate but has a longer period of pharmacological activity
generally allowing for 1 or 2 daily doses.
The second line of treatment involves the use of tricyclic antidepressants
(TCAs), especially imipramine and desipramine, which are generally effective in
combination with stimulants for the treatment of comorbid disorders such as
depression (Biederman, 1998). Although TCAs are longer acting than stimulants and
allow greater dosing flexibility they are highly toxic and have a very narrow
therapeutic margin. Common adverse effects of the TCAs include anticholinergic
effect characterized by dry mouth, blurred vision, and constipation (Gelenberg et al.,
1997).
Self-medication Hypothesis o f Drug Abuse
The use of stimulant medication (e.g. methylphenidate, dextroamphetamine)
has been also shown effective in the treatment of substance abuse in adults with
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ADHD (Schubiner et al., 1995). ADHD has been reported to significantly increase the
risk for substance use disorders independently of psychiatric comorbidity status
(Biederman et al., 1995). Adults with ADHD are twice as likely to abuse drugs and
four times as likely as normal controls to abuse drugs in combination with alcohol
(Biederman et al., 1995). Most commonly they tend to use marijuana and to a lesser
degree stimulants, cocaine, and hallucinogens (Biederman et al, 1995). It has been
hypothesized that individuals with ADHD could be using different substances to
ameliarate psychiatric symptoms and the distress associated with them (Khantzian,
1985).
This self-medication hypothesis for substance abuse was originally based on
the psychodynamic perspective that drug addicts choose a particular drug not so much
because of its pleasurable aspects but to a greater extent because of its interaction with
specific psychiatric disturbances observed in these individuals (Khantzian, 1985). For
example, early psychodynamic research suggested that individuals abusing
amphetamines choose the drug on the basis of its stimulating action to support an
inflated sense of self-worth and a defensive style involving active confrontation with
their environment (Milkman & Frosch, 1973). On the other hand opiates were shown
to be often us°d by depressed individuals as an attempt at self-treatment for feelings
of extreme dysphoria, pain and stress (Rounsaville et al, 1982). Opiates were further
shown to produce strong calming and anti-aggression effects, which have been
regarded as the primary reason for their appeal to individuals with histories of poor
anger management skills and violent behavior (Khantzian, 1985). Finally, abuse of
cocaine has been linked to attempts to overcome fatigue and depletion associated with
depression as well as to increase feelings of assertiveness, self-esteem, and frustration
tolerance and to counteract boredom and feelings of emptiness (Khantzian, 1985).
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The self-medication hypothesis has received further support in more recent
studies directly examining association between substance abuse and ADHD. For
example, in a study by Shubiner et al. (1995) administration of methylphenidate as
well as dextroamphetamine to ADHD adults with alcohol dependence have been
found to significantly reduce craving for alcohol and its subsequent use. The
neurotransmitter dopamine has been implicated in the mediation of reward and
reinforcement for alcohol abuse (Koob, 1992). It has been further found that a
particular dopamine agonist, bromocriptine, reduced cravings in alcoholics (Borg,
1983). Schubincr et al. (1995), therefore, suggested that the effectiveness of stimulant
medication in treating alcohol abuse could be linked to the drug-induced increase in
oopamine and norepinephrine turnover, which could also explain the efficacy of these
drugs in ADHD. Adults with ADHD have reported feeling calmer, being able to
concentrate better and noted reductions in distractibility, frustration and restlessness
following chronic administration of psychostimulants (Schubiner et al., 1995).
Despite considerable research attention given to various pcychoactive
substances abused by adults with ADHD, Hughes (1997) noted that surprisingly little
consideration in the research literature has been given to nicotine dependence.
According to Pomerlau et al. (1996) 40 percent of adults with ADHD smoke
cigarettes on a daily basis compared to 26 percent of the general population.
Additionally, nicotine has been found to improve attention and concentration on
vigilance tasks as well as to significantly reduce clinical symptoms of ADHD (Levin
et al, 1996). It is, therefore, possible that in addition to treatment of affective
symptoms nicotine abuse in the ADHD population could also be related to the
alleviation of attentive and cognitive symptoms, and these effects could be more
prominent with nicotine than with other more affectively potent substances such as
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marihuana and cocaine (Biederman et ai., 1995). This possible interaction of nicctine
with the ADHD symptomatology could, thus, play an important role in explaining the
prevalence and maintenance of tobacco use by individuals with ADHD and should,
consequently, attract further research inquiries.
Nicotine
Despite relatively few studies directly examining effects of nicotine on
ADHD symptomatology, its general pharmacological action and cognitively
enhancing effects have been extensively investigated across a variety of clinical and
normal populations (e.g. Decker et al., 1995; Levin, 1992). It is a very potent poison
and a highly addictive substance that is found in tobacco, which comes from a plant
Nicotiniana tabacum (Goodman & Gilman, 1983). The effects of nicotine depend
critically on the dose administered and the speed with which it is delivered (Benowitz,
1996; Henningfleld et al., 1993). In humans the primary system of nicotine delivery is
via the lungs by means of cigarette smoking. In the range of doses absorbed from
smoking nicotine has relatively minor stimulant and depressant effects. It is known
that in the brain nicotine is concentrated in the gray rather than the white matter and
primarily acts as a cholinergic agonist, mimicking the activity of acetylcholine on
post-synaptic nicotinic receptors (Goodman & Gilman, 1983).
The structural basis for the pharmacological activity of nicotine on nicotinic
ionic receptors is its tesemblance to acetylcholine (ACh) in terms of the spacing of
positive and negative chargers (Mangan and Golding, 1983). Nicotine, however, is
only selective for one type of the receptor that ACh can bind to - the nicotinic
receptor. Its failure to bind to muscarinic receptors is due to the fact that the nicotine
molecule has a rather limited range of conformations that it can assume compared to
ACh (Goodman & Gilman, 1980). The excitatory action of nicotine nACr.Rs can
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cause the secondary release of a variety of transmitters, depending on the type of
neuron activated, including ACh itself, noradrenaline (NA), serotonin (5HT),
dopamine (DA), and peptides (Benowitz, 1996). Therefore, nicotine produces effects
throughout the nervous system.
Nicotine and Addiction
Despite its pharmacological versatility addictive properties of nicotine have
been linked to its effect on the mesolimbic dopamine system (Benowitz, 1996).
Specifically, the nucleus accumbens has been shown to play an important role in
reinforcing effects of other drugs of abuse, such as amphetamine, cocaine, opiates,
PCP, and cannabis (Di Chiara, 1995). The reinforcing effect of nicotine appears to
occur in the VTA where it increases firing of dopaminergic neurons facilitating
release of dopamine (Benowitz, 1996). Museo and Wise (1994) found that injection of
a nicotinic agonist (cystine) directly in the VTA reinforced a conditioned place
preference in rats. Conversely, direct injection of a nicotinic antagonist into the VTA
resulted in attenuation of the reinforcing effect of intravenous injections of nicotine
(Corrigall et al., 1994). Similar injections of a nicotinic antagonist into the nucleus
accumbens, however, did not produce an effect on reinforcement (Corrigall et al.,
1994). Finally, Nisell et al. (1994) have found that injection of a nicotinic antagonist
into the VTA prevented release of dopamine in the nucleus accumbens following
nicotine treatment. Fung et al. (1996) have observed a dramatic decrease in the level
of dopamine in the nucleus accumbens following withdrawal from chronic nicotine
administration. It thus appears that the VTA is more involved in the reinforcing
effects of nicotine while the nucleus accumbens is primarily concerned with nicotine
withdrawal.
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Besides dopamine nicotine has also been found to ♦rigger release of other
neurotransmitters such as serotonin and norepinephrine, particularly in the
hippocampal area (Joseph et al., 1990). These neurotransmitters are implicated in the
effects of some antidepressants (e.g. Bupropion, tricyclics), and it has been reported
that some smokers self-administer nicotine to treat affective disorders (Rose et al.,
1993). In addition to the reinforcing effect of nicotine in the VTA, behavioral rewards
from nicotine appear to be linked to dopamine release in the nigrostriatal region.
Conversely, some smokers become severely depressed when they stop smoking
(Benowitz, 1996).
Cholinergic Hypothesis
Outside the mesolimbic system a particularly high number of nicotinic
receptors have been found in the cellular layers of the hippocampus (Fujii et al.,
1999). The hippocampus is part of an extensive cholinergic system consisting in the
human brain of eight closely interconnected and largely overlapping groups of cells
that are located at all brain levels starting from the basal forebrain and continuing
through the diencephalon and the striatum to the brain stem and the spinal cord (Gotti
et al., 1997). The greatest cholinergic input to the cortex is accomplished by the
magnocellular basal complex, a group of cholinergic neurons located in the basal
forebrain, which also provides input to the hippocampus. Specifically, the neurons in
the medial septum innervate the hippocampus and entorhinal cortex. The cells of the
diagona' band of Broca send projections to the amygdala, habenular nuclei, and the
cingulate cortex, while cholinergic neurons in the nucleus of Mayncrt innervate the
frontal, parietal and occipital cortex and also project to the reticular nucleus of the
thalamus (Gotti et al., 1997).
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The hippocampus has long been known to play an important role in
attentional processing and memory (Jarrard, 1995). For example, animal studies
revealed that the hippocampus could be involved in spatial memory and motivation.
Specifically, significant increase in the release of hippocampal ACh has been
observed in rats that have learned a specific task in comparison to a control groop
(Stancampiano et al., 1999). In their study Stancampiano et al. (1999) assessed the
role of hippocampal serotonin (5HT) and acetylcholine (ACh) in the perfi/imance of a
learned task. The researchers used intracerebral dialysis procedures which enabled
them to take continuous measurements of extracellular levels of ACh and 5-HT in the
hippocampus while rats performed a food-reinforced radial-arm maze task.
Four groups of male Sprague-Dawley rats were used in the study. The first
group (trained, rewarded group) was trained in an eight-arm radial maze consisting of
an octagonal central area and eight oOxlO cm extensions each terminating in a food
cup. Training involved four consecutive trials on each day. In the first trial each rat
was individually placed in the central area of the maze and allowed to explore only
four of the eight arms baited with food (access to the other four extensions was
prevented by a removable guillotine door). After all baited arms had been visited a rat
was removed from the maze and returned to its cage. During the remaining three trials
all eight radial arms were opened and the rat remained in the maze for 10 minutes and
was required to visit each of the four re-baited arms once. A correct trial was
recorded, if the animal entered only the baited arms, and each arm was visited only
once. Failure to enter one of the baited arms, revisiting a previously attended arm, or
failure to consume the food reward after entering one of the re-baited arms was scored
as error. Before each training session each rar was placed in a waiting cage for 10
minutes. After 10 training days, each comprising four trials, the rats underwent
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surgery during which a dialysis probe was implanted in the dorsal hippocampus. The
dialysis probe consisted of a membrane and a wet tube with a diameter of 320pm.
Forty-eight hours after the surgery and 23 hours after their last feeding, the
performance of the rats was assessed in the maze with concurrent microdialysis
sampling. Behavioral testing consisted of two consecutive 10-minute sessions with
neurotransmitter measures being taken at 10-minute intervals. Acetylcholine and
serotonin sampling continued for thirty minutes after the completion of the second
testing session and was compared together with the test measurements to the baseline
levels obtained 60 and 180 minutes after stabilization (less than a 10% differences
among three consecutive samples).
The second group of rats (trained, non-rewarded group) was trained and tested
exactly like the first one with the only difference that during the testing sessions no
food rewards were available in the end of each of the four previously baited arms of
the maze. The third group was tested without any prior exposure to the maze with
sunflower seeds scattered randomly on the floor (non-trained, rewarded group).
Finally, a fourth group of rats was introduced to the maze for the first time on the
testing day and their exploration was not reinforced with any type of food (naive
group). The second and the third groups were used to determine separate
contributions of feeding and test performance on neurotransmitter release.
The results showed that when compared to the baseline value, the trained,
rewarded group exhibited an increase in the extracellular ACh concentration to 180%
during the waiting period, and a further increase to 235% during the radial-maze task,
which remained significantly elevated 10 minutes after the completion of the task. At
the same time no significant increase was noted for 5HT during the waiting period but
a significant elevation to 142% of basal levels was observed during and 10 minutes

23

after the end of the radial-maze task. In the trained non-rewarded group the increase
in ACh was only observed in the waiting period (168%) while no further increase
occurred during the radial-maze task with unbaited arms. No significant changes in
the levels of 5HT were observed in this group either during the waiting or the testing
periods. In the non-trained rewarded group a gradual increase to 150% was observed
during their exploration of the maze baited with randomly scattered sunflower seeds.
Similar gradual increase to 130% of baseline was observed for 5HT. The naive group
of rats showed a significant increase in ACh during the first 10 minutes of their
exposure to the maze while no significant fluctuation was noted for 5HT.
The researchers concluded that since increases in ACh were observed in both
trained groups during the waiting phase this neurotransmitter could be associated with
motivational aspects of the task previously reinforced by a palatable food reward.
Furthermore, since ACh elevations were also observed in trained non-reinforced and
in naive rats during their exploration of the maze its relation to cognitive processes
involving spatial memory could also be proposed. Since no significant changes in the
levels of 5HT were noted either in the waiting period or in trained, non- reinforced
rats, the involvement of this neurotransmitter in either motivation or memory and
attention does not seem to influence these functions significantly. However, the
increased release of both types of neurotransmitters in response to palatable food
rewards indicates that the hippocampus (apart from its cognitive function) might also
be involved in feeding behavior.
Further evidence in support of the role of the hippocampus in spatial memory
comes from studies in which performance of rats with selective lesions in the
hippocampus has been assessed on a number of tests measuring various aspects of
memory. Specifically, the converging findings from the spatial radial maze studies
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(Bouffard et al., 1988; Jarrard et al., 1986), the Morris water maze task (Morris et al.,
1990) and the rewarded alteration test (Jarrard et al., 1994) indicate that rats with
selective hippocampal lesions are severely impaired in acquisition of spatial
information but do not show impairment in their learning of other non-spatial tasks.
Removal of the cells that comprise the hippocampus only (pyramidal cells, dentate
gyrus) became possible with the introduction of micropipette injections of ibotenic
acid at multiple sites within the hippocampus.
For example, Jarrard et al. (1995) have reported findings of a series of studies
in which rats with selective ibotenic acid-induced lesions to the hippocampus were
compared to non-lesioned rats on the radial eight-arm maze task which examined two
types of acquisition of information (spatial versus intramaze cues) and two different
memory functions (reference memory versus working memory). While the spatial
component of the task involved palatable food rewards after correct identification of
the same four baited arms of the maze, in the intramaze cue task the rat was rewarded
for choosing the same four cues (different textured floor inserts: screen wire, carpet,
hardware cloth, sandpaper etc.) moved among the eight arms in random order
independently of spatial location. Errors in reference memory were recorded when
the rat made a choice of either the arm or the cue that was never baited. Working
memory was assessed in terms of two types of errors. Correct working memory errors
occurred with repeated attendance of the previously visited baited arms (selection of
baited cues), while incorrect errors involved repeated entries into non-baited arms
(choice of non-baited cues).
The results showed that rats with hippocampal lesions made a significantly
greater number of errors (both reference and working memory) in learning the spatial
version of the task than the control, non-lesioncd group. At the same time no
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significant impairment was observed in the intramaze cue task. In fact, by the end of
the training period rats in the lesioned group were making significantly fewer errors
than the controls. The researchers hypothesized that this facilitated performance could
be due to faster availability of a non-spatial learning strategy for the lesioned group
lacking in ability to use a spatial strategy in learning the task.
A subsequent lesion study by Levin et al. (1999) provided additional support
to the role of the hippocampus in spatial memory and directly examined the effect of
nicotine injections on this type of memory. Similarly to the methodology of Jarrard
(1995) ibotenic acid was used to induce selective lesions in the hippocampus of
female rats performing an eight-arm radial maze task. After 18 training sessions the
rats were divided in four matched groups. In two of the four groups the animals
sustained lesions in the ventral hippocampus and received subcutaneous implants of
osmotic minipumps that delivered either a 5mg/kg/day dose of nicotine or vehicle.
The other two groups of rats were treated in the same surgical manner but no lesions
were induced (sham-operated). Both groups were also equipped with minipumps
delivering either nicotine or vehicle. After recovery, the rats were tested on the radial
arm maze three times per week for four consecutive weeks, which enabled the
researchers to examine chronic effects of nicotine on spatial memory.
The results showed that in the sham-lesioned group chronic nicotine infusion
caused a significant improvement in choice accuracy. Conversely, administration of
nicotine to the hippocampal lesion group did not result in any significant
improvement in working memory, and this blockade of the nicotine effect was
observed in the absence of significant working memory impairment despite the
induced lesion. On the basis of these findings and in view of the previous evidence the
researchers hypothesized that the critical nicotinic receptors in the hippocampus
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There are several different types of nicotinic cholinergic receptors which
comprise a family of ACh-gated ion channels classified on the basis of their
constituent subunits and found both in muscle and the nervous system. Eleven
nAChR subunits have been so far identified and divided into two subfamilies of eight
a and three p subunits. The muscle a subunit is known as a l, and the eight neuronal
subunits are respectively numbered from a 2 to a9. The three P subunits found in the
nervous system are known as P2-P4. While the a subunits are primarily associated
with their role in the formation of agonist binding sites, the P subunits are considered
structural subunits, although both types of subunits have been shown to contribute
towards the pharmacological specificity of AChR. subtypes (Gotti ef al., 1997). The P
subunits appear to regulate the rate at which both agonists and antagonists dissociate
from the receptor subtypes, as well as the rate at which agonist bound subtypes open
(Papke, 1993).
At least two different classes of nAChRs have been identified in the nervous
system: those that contain receptor molecules that bind 5H-agonists with nM affinity
but not aBungarotoxin (aBgtx) and those with receptor molecules that bind agonists
with pM affinity and aBgtx with nM affinity (Lukas and Bencherif, 1992). The most
abundant subtype found in the vertebrate brain is the a4p2 subtype, which accounts
for most of the high-affinity 3H-agonist binding sites (Whiting and Lindstrom, 1986)
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while the a7 subtype accounts for the most of the high-affinity aBgtx binding sites
both in the central and peripheral nervous systems (Keyser et al., 1993).
The a4(32 subtype has been reported to mediate nicotine- induced effects on
attention and accuracy of responding assessed by a five-choice serial reaction time
task (Grottick et al., 2000). In a series of studies Grottick et al. (2000) investigated
effects of nicotine on performance of male Lister Hooded rats in the five-choice serial
reaction time task. The task involved placement of rats in an operant chamber
containing on one wall a food hopper and house light and on the opposite wall an
array of five square holes with a light source at the rear of each hole. Training began
with the illumination of the house light and delivery of a food pellet. The first trial
commenced with the first nose poke into the magazine tray followed by random
illumination of one of the five lights for a fixed interval. This illumination interval
was termed Stimulus Duration (SD), while the period of time between any two
illuminations was known as an inter-trial interval. A correct response was registered if
the rat poked its nose in the illuminated niche either before the end of the SD or a
fixed interval after this period (limited hold, LH). If a correct response was recorded,
another food pellet was administered. If, however, a rat failed to respond in the
allotted interval (missed trial) such a response was considered incorrect resulting in a
time out (TO) period in which the house light was extinguished for 5 seconds. If a rat
responded to one of the five niches during the ITI (premature response), or after a
correct trial was registered (perseverative response), time out was again enforced.
Finally, if a rat poked its nose in one of the niches during the TO, the TO was
restarted.
For their first experiment the researchers selected only those rats that
continued to perform below the threshold criterion of 75% correct and less than 20%
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omissions for at least a 2- week period after the rest of the subjects had already
achieved the required parameters. This selection was made to avoid possible ceiling
effects that couid be observed after the use of agonist treatment. The selected animals
were further divided into three groups. During the first week (for 5 days Monday
through Friday) all groups performed under normal conditions to obtain baseline
measures. During the second week (5 days) each group was further divided into
experimental and control subgroups, with one half of the subjects (n=5) receiving an
injection of vehicle and the other (n=5) - one of the three tested nicotine agonists
(nicotine, AR-R 17779, or SIB 1765F). While the AR-R 17779 agonist exhibits
greater binding selectivity for a7 receptors, SIB 1765 has been demonstrated to target
a4p2 receptors (Sacaan et al., 1997). After each pre-treatment the animals were again
tested in the 5-CSRTT for 5 days. During the third week a further 5-day period of
baseline performance was assessed in the absence of any drug treatment.
The results showed improved accuracy in performance during the second
week of testing for the nicotine and SIB 1765F groups in comparison to saline
controls and baseline measures taken during weeks 1 and 3, respectively. Both agonist
groups also demonstrated a significant decrease in the number of omissions and an
increase in premature responses. Significant decrements in performance (decrease in
correct responses), however, wore observed after pre-treatment with AR-R 17779.
In the second study a similar BAB design was employed using three nicotinic
antagonists (mecamylamine, MLA, and DH(3E) in animals performing at target
criterion (over 80% correct and less than 20% omissions). Mecamylamine is the most
widely used centrally active noncompetitive nicotinic antagonist. It does not inhibit
acetylcholine or nicotine binding in the rat brain but blocks the nicotine- induced
release of dopamine from the rat striatum (El-Bizri and Clarke, 1994). On the
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contrary, DHpE is a competitive antagonist while MLA is a7-selective (Grottick et
al., 2000). The results showed that administration of mecamylamine was followed by
a reduction in the percentage of correct responses, an increase in the latency of correct
responses and an increase in the number of omissions. No significant changes in
performance, however, were noted for either MLA or DHpE.
Chronic nicotine effects were also determined in two groups of animals that
had received at least 20 daily injections of either nicotine or vehicle. Nicotine was
administered pseudo-randomly over four treatment cycles. The results showed that
chronic nicotine administration significantly altered the response to acute nicotine
challenge. Specifically, no visible improvement in performance was observed for
those rats that were not sensitized to nicotine, while in sensitized rats nicotine
decreased correct latency, increased premature responding and increased percent
correct responses.
Finally, after the amelioration of performance was induced by chronic nicotine
administration the subjects were administered nicotine/antag mist combinations
(either MLA or DHPE) in a 2 x 2 factorial design over four treatment cycles. The
results indicated reversal of nicotine-induced correct latency reduction and increase of
premature responses following administration of DHpE. No significant interaction of
nicotine with MLA was observed.
The researchers suggested that since enhanced performance was observed for
both nicotine and SIB 1765F but not for AR-R 17779, attentional effects of these
agonists are most likely mediated by the a4p2 receptor which has also been
implicated in DA release (Kulak et al., 1997). The researchers further hypothesized
that some of the nicotine induced DA release could have occurred in the nucleus
accumbens since increased accumbens DA release had been previously found
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sensitive to antagonism by mecamylamine and DHpE (Menzaghi et al., 1997) which
in their study reversed some of the nicotine-induced improvements. Specifically, the
researches proposed that the accumbens DA release mediated the observed decrease
in response latency and the increase in premature responses because lesions to this
area had been found to increase omissions, increase latencies, and reduce premature
responses (Cole, 1989). On the other hand, the researchers further noted that the
observed improvement in the accuracy of responding was probably mediated by
cholinergic systems since cholinergic lesions primarily affect this aspect of
performance (Inglis et al., 1999). It is likely that nicotine induces an increase in
cholinergic tone also mediated by a4^2 receptors that is necessary for accurate
stimulus identification under conditions of low stimulus detectability.
Although AR-R 17779, which primarily targets a l receptors, did not produce
any improvements in performance (on the contrary, its effect on response accuracy
was detrimental), the functional role of the a l - subtype has not yet been conclusively
established. It has been found that it is especially abundant in the rat hippocampus and
could, therefore, be involved in the hippocampal processing of information (Rezvani
et al., 2001). For example, Gray et al. (.’ 996) investigated the role of nicotinic
cholinergic receptors (nAChRs) through application of 0.5pM of nicotine to rat
hippocampal slices. The researchers found that CA3 pyramidal neurons in the rat
hippocampus responded to nicotine with an increased rate of spontaneous miniature
excitatory postsynaptic currents (mEPSCs). In particular, application of nicotine
increased the frequency but not the amplitude of the mEPSCs, and this enhancement
was mediated by a l nAChRs since no mEPSC enhancement following nicotine
administration was observed when the nAChRs were blocked by a-Bungarotoxin (aBGT), a nicotine antagonist targeting primarily a l receptors (Gotti et al., 1997).
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Furthermore, the results indicated that external Ca2+ is required for nicotine
enhancement of mEPSC since presynaptic activation of nAChRs by nicotine leads to
increased Ca2+ influx into the terminal which, in turn, greatly increases the
probability of neurotransmitter release (Gray et al., 1996). Because transmitter
release usually depends on the fourth power of intra-terminal Ca2+ concentration,
nAChR activity could, therefore, enhance release and facilitate synaptic transmission.
Consequently, proper timing of nAChR activity could ensure cohesiveness of synaptic
events emerging from the noise of synaptic probabilities (Gray et al., 1996). The
researchers further suggested that this timing function of nAChRs may be particularly
diminished in Alzheimer's disease.
This functional degradation could result from degeneration of nicotinic
receptors in the hippocampus that has been observed in Alzheimer's patients (Jones, et
al., 1992). It has been suggested that the profound cognitive impairments
characteristic of Alzheimer's disease are primarily caused by the degeneration of the
forebrain cholinergic systems. The principal focus of earlier investigations mostly
concerned muscarinic cholinergic receptors since the muscarinic blocker scopolamine
had been consistenly shown to impair performance on memory tasks (Levin, 1992).
Muscarinic receptors, however, have been reported to be less affected by Alzheimer's
disease than nicotinic ones (Perry et al, 1986). Additionally, excitation of muscarinic
receptors has not been shown to produce therapeutic effects in patients with the
disease when administered chronically due to the fact that over time these receptors
exhibit downregulation (Marks et al., 1985). Consequently, any cognitively
enhancing action of muscarinic agonists is attenuated by the loss ligand-binding sites
over time. Nicotinic receptors, on the other hand, show upregulation induced by
chronic nicotine administration, which in itself presents a paradox (Marks et al.,
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1985). It is generally accepted that the overstimulation induced by agonists leads to a
reduction in the number of cell surface receptors, whereas the prolonged inactivation
induced by antagonists produces the opposite effect (Gotti et al., 1997). One possible
explanation of the increased number of nicotinic receptors following long term
exposure to nicotine considers the fact that neuronal nicotinic receptors undergo rapid
desensitization and subsequent inactivation which, in turn, can be counteracted by an
increase in their number (Gotti, et al., 1997). Recent evidence seems to be in
agreement with this hypothesis since nicotine treatment was found to increase the
expression of nicotinic receptors by decreasing the rate of the receptor turnover,
which probably relies on conformational modifications that prevent the receptor to be
removed from the cell surface (Gotti, et al., 1997).
Specifically, in a number of studies (e.g. Abdulla et al., 1996; Collins et al.,
1990; El-Bizri and Clarke, 1994) chronic nicotine administration in rats produced an
increase in the number of a4p2 and a7-bearing receptors. Therefore, the use of
nicotine in therapy would be less likely to produce decrements in cognitive
performance attributed to receptor loss. Consistent with this hypothesis, Jones et al.
(1992) found that when treated subcuteneously with three acute doses of nicotine (0.4,
0.6 and 0.8 mg) patients having dementia of the Alzheimer type (DAT) showed
significant improvements in perception, sustained visual attention, rapid visual
information processing and reaction time measures. In another study (White and
Levin, 1999) chronic transdermal administration of nicotine to Alzheimer's patients
over 4 weeks (5mg/day during week 1 and 4, and lOmg/day during weeks 2-3)
resulted in significant improvement of attentional performance as measured by the
Conners' continuous performance test (CPT). This improvement was characterized by
a significant reduction in errors of omission and variability of hit reaction time. It has
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been, therefore, suggested that cognitive functioning might be mediated by
cholinergic systems, and cholinergic agonists such as nicotine could be used to boost
both pre- and/ or post-synaptic activity of these systems to improve performance on
measures on cognition (Jones et al., 1992).
Another possible mechanism of cognitive enhancement mediated by
cholinergic systems could involve the effect of nicotine on the strength of synaptic
signals in the hippocampus. It has been previously found that the administration of a
brief, high frequency train of stimuli (a tetanus) to any of the synaptic pathways in the
hippocampus resulted in an increase in the amplitude of excitatory postsynapiic
potentials in the target hippocampal neurons (Bliss and Lomo, 1973). This
stimulation- induced change in synaptic strength can persist for relatively long periods
and has been, consequently, termed long-term potentiation (LTP) (Kandel, 2000).
Long-term potentiation is considered a leading candidate for cellular mechanisms
underlying learning and memory (Kandel, 2000). Fujii et al. (1999) investigated
whether the excitatory' cholinergic action of nicotine facilitated the induction of LTP
in the hippocampus. Although a previous study by Gray et al (1996) did not show any
changes in the amplitude of nicotine induced mEPSCs (see discussion above), Fujii et
al. (1999) found that when tr ansverse slices of rat hippocampi were exposed to weak
titanic stimuli (10 to 15 pulses at 100 H z) LTP was induced only in the presence of
acute doses of nicotine (1 and 10 pM but not 0.1 pM) and not when the tetanus was
presented alone. Presence of nicotine by itself without any titanic stimulation was
also insufficient to produce LTP (which is consistent with the findings of Gray et al.,
1996). The LTP-inducing effect of nicotine was completely blocked by administration
of mecamylamine (a nAChR channel blocker) indicating a direct interaction of
nicotine with nAChRs during LTP induction. The researchers suggested that doses

34

between 0.1 and lpM of nicotine are needed to induce LTP. Since smoking a single
cigarette delivers about 0.5 pM (Fujii et al., 1999) the researchers hypothesized that
acute administration of nicotine can thus result in improved cognitive performance in
smokers.
The researchers also found that when rats were treated with lmg /kg of
nicotine twice a day for 10 to 17 days LTP was observed in the presence of weak
titanic stimuli (10 to 1 pulses at 100Hz). Chronic nicotine administration also resulted
in an increase in the number of a 4 $ 2 and a7-bearing nAChRs in the hippocampus.
The researchers suggested that because LTP induction following acute nicotine
treatment remains after its chronic administration smokers might also derive cognitive
benefits from chronic nicotine delivery. Since each smoked cigarette brings about
0.5pM nicotine that is superimposed on a chronic nicotine level of about 0.1 pM the
concentration of nicotine may still be within effective levels with each cigarette
smoked.
D opam inergic H ypothesis

Another mechanism of nicotinic enhancement of cognitive functioning has
been attributed to the induction of dopamine (DA) release in the substantia nigra,
ventral tegmental area (VTA) and the striatum where the densities of nicotinic
receptors are among the highest in the brain (Clarke et al. 1984; Clarke and Pert,
1985; Schwartz, 1986). Dopaminergic cells in these areas appear to respond with DA
release to the presynaptic binding of nicotine to their a3 cholinergic nicotinic
receptors, while similar induction of the ACh release in the frontal cholinergic
systems is mostly associated with a4(32 and <xl (Levin, 1992). It has been
hypothesized that if improvements in cognitive functioning arise from the
dopaminergic action of nicotine then this effect can be directly tested through DA
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blockade in the above regions. Unlike the cholinergic blockade with mecamylamine,
DA receptor blockade has been studied in humans treated with antipsychotic
preparations to attenuate symptoms of schizophrenia (Levin et al, 1996). A commonly
used antipsychotic drug haloperidol (Haldol) causes a number of cognitive
impairments and extrapyranudal symptomes that include Parkinson's syndrome
induced through dopaminergic (D2 receptor) blockade in the substantia nigra and the
striatum.
Levin et al. (1996) found that nicotine delivered via a patch caused a doserelated reversal of cognitive impairments induced by the administation of haloperidol
to a group of smokers diagnosed with schizophrenia. In this study 15 smokers (3
females and 12 males) who had smoked on average 21.3 cigarettes a day for more
than 2 years were started at 2mg of haloperidol treatment a day. At 2-3 day intervals,
the haloperidol dose was increased by 2mg/day until a neuroleptic threshold (NT)
characterized by bradykinesia rigidity was reached. At this point the patients were
randomly assigned to low (one-third of the NT dose), medium (the NT dose) and high
(three times the NT dose) doses of haloperidol in a double-blind manner for 4 weeks.
Extrapyramidal symptoms induced by the drug were counteracted by administration
of a benzotropine (Cogentin). At the end of the fourth week each subject was treated
with a nicotine patch containing 0, 7, 14, and 21 mg of nicotine in a randomized
counterbalanced fashion. Three hours following the administration of the patch
participants' performance was assessed on measures of simple reaction time, complex
reaction time (spatial rotation), delayed matching to sample, memory (modified
Sternberg's task) and sustained attention (Conner's CPT).
In the simple reaction time task the participants were asked to press a key on
the computer keyboard as soon as a snowflake image appeared on the computer
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screen. In the complex reaction time test the participants were asked to determine as
quickly as possible by pressing a corresponding key whether a four bar histogram
appearing on the computer screen was the same as another pattern rotated by 90 to
270 degrees. In the delayed matching to sample test the participants weic asked to
identify which of the two 4 x 4 matrixes of light and dark squares had been presented
on the screen on the preceding trial. The modified Sternberg memory test involved a
set of two to six letters shown in the middle of the screen followed by presentation of
single letters. The participants were asked to identify by pressing a corresponding key
whether the displayed letter was part of the previously shown set.
The results demonstrated that 7 and 14 mg of nicotine (but not 21 mg) reversed
cognitive slowing, bradynhrenia, caused by the medium dose of haloperidol on the
spatial rotation task (complex reaction time). The 21 mg of nicotine patch, however,
significantly attenuated the more dramatic slowing caused by the high dose of
haloperidol. Both medium and high doses of haloperidol caused significant
impairment on the delayed matching to sample task as compared to the low dose in
the absence of nicotine delivery. These deficits were most effectively attenuated in
both the medium and high haloperidol groups with the 14 mg of nicotine patch, while
the 21mg/day dose was only effective in eliminating the impairment in the medium
haloperidol group. The 7mg of nicotine dose did not significantly affect the
haloperedol-induced deficits. The CPT test showed that nicotine reduced the
variability in response speed across fne different interstimulus intervals. This effect
was not different across the three doses of haloperidol. Hit reaction time decreased
with the 7 and 14 mg of nicotine but increased with the 21 mg patch. The 21 mg of
nicotine dose, however, produced a significant decrease in variability of standard
error of hit reaction time.
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The researchers suggested that with less cognitive impairment a higher dose of
nicotine (21 mg) could have exceeded a therapeutic window even for heavy abstaining
smokers. It has been reported that many cholinergic drugs such as physostigmine, for
example, can impair cognitive performance if the window is exceeded (Jones et al.,
1992). Low (0.5 mg /kg or less) but not high does of nicotine have been reported
improve passive avoidance in rats (Haroutunian et al., 1985).
Consistent with the self-medication hypothesis the results of the study by
Levin et al., (1996) suggest that schizophrenics may smoke cigarettes at least partially
to attenuate the adverse motor and cognitive side effects of antipsychotic drugs. It is
possible that nicotine-induced amelioration of cognitive deficits resultant from
haloperidol administration was mediated via the action of nicotine on dopaminergic
cells in the striatum and the substantia nigra that were directly blocked by the
neuroleptic. Nevertheless, nicotine could have still beneficially affected cognitive
performance through its cholinergic rather than dopaminergic action since in that
study extrapyramidal symptoms were reversed with clozapine. Other researchers (e.g.
Decina et al., 1990; Jarvic et al, 1996), however, have found that schizophrenics who
smoked had significantly lower rates of neuroleptic-induced Parkinsonism, and
haloperidol administration also increased smoking in non-schizophrenic participants.
Additionally, in a study by McEvoy et al. (1995) haloperidol caused a dose-related
increase in ad-lib smoking while clozapine produced a significant decrease in
smoking. This evidence indicates a direct relationship between nicotine and
dopaminergic systems suggesting that cognitive improvements observed by Levin et
al. (1996) in schizophrenic patients were at least partially produced by the agonist
action of nicotine on dopamine cells in the striatum and the substantia nigra.
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A more recent post-mortem study by Court et al. (1998) offers an alternative
explanation of greater dopamine availability in the striatum of smokers that could
explain cognitive and motor improvements observed in schizophrenic patients. The
researchers examined striatal, hippocampal, and cerebellar brain tissues of deceased
elderly smokers, ex-smokers and non-smokers and did not find any significant
difference in the number of binding sites for either D1 or D2 receptor subtypes in any
of the above brain areas among the three autopsy groups. Nevertheless, the
researchers did find significantly greater dopamine levels in the caudate and putamen
of smokers compared with non-smokers. The researchers suggested that elevated
dopamine levels could be explained by reduced dopamine neuronal firing suggesting
reduced dopamine turnover, which may be produced through receptor desensitization,
which unlike cholinergic receptors do not show subsequent upregulation.
Additionally, greater high affinity nicotine binding was also found for smokers in all
of the investigated brain regions in comparison to either non-smokers or ex-smokers,
with the greatest difference found in the hippocampus and the smallest observed in
the striatum. These data may reflect variation in subtype composition of receptors in
different brain areas and different subtype responsiveness to nicotine exposure since
the striatal structures contain primarily a3 receptors, while the hippocampus is replete
with a l and a4p2 receptors (Levin et al., 1992). Furthermore, both a7 and cc4p2
receptors have been found to be more sensitive to desensitization than a3 containing
receptors (Hsu et al., 1996).
Consistent with the findings of Court et al. (1998) those schizophrenic patients
who smoke cigarettes have been shown to have elevated high-affinity nicotine
binding in the striatum but reduced high-affinity binding in the hippocampus
(Freedman et al., 1995), which could reflect a hippocampal deficit in schizophrenia.
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Greater nicotine binding observed in the striatum could correspondingly increase
dopamine availability. Since reduced dopamine turnover has been observed in
smokers, it could be of symptomatic benefit to schizophrenic patients who, according
to recent hypotheses of the illness, experience excessive fluctuation of dopamine
(Gilbert, 1996).
Studies in Normal Adults
In a review of over 100 studies examining effects of nicotine on cognitive
performance of normal adults Heishman et al. (1994) also discussed specific effects of
nicotine on different measures of attention including focused, selective, divided and
sustained attention. On the measures of focused attention nicotine was not found to
reliably enhance the ability to focus attention on a single task for a brief period of
time or enhance the psychomotor response required in such tests. Similarly, weak
evidence was found for nicotine to support a hypothesis of enhancement of selective
attention in abstinent and non-abstinent smokers and nonsmokers. For the measures
of divided attention modest nicotine-induced enhancement was observed in tracking
performance but no change was found in reaction time. Sustained attention was
studied in a variety of vigilance tasks, and the overall results indicate moderate effect
of nicotine on prevention of the performance decrement observed over time.
Heishman et al. (1994), however, noted that a great number of experiments
used abstaining smokers. Consequently, the observed improvements could have been
produced by withdrawal relief rather than direct cognitive enhancement. Furthermore,
the researchers pointed out that daily smokers are never completely nicotine free and
a variable dose of nicotine administered to smokers in different experiments does not
allow to accurately establish the impact of nicotine due to the unknown preexisting
plasma nicotine concentration. Another criticism referred to the use of cigarettes as a

40

nicotine delivery system. For instance, it is well known that people differ in their
puffing and inhalation strategies and are able to adjust their smoking behavior to
compensate for actual or perceived changes in the nicotine yield of cigarettes (Gust &
Pickens, 1982; Heming et al., 1981). Thus, the use of cigarettes varying in nicotine
yield does not guarantee effective dose manipulation. Finally, the use of cigarettes
does not allow for the use of an effective placebo control. However, previous research
using an alternative nicotine delivery system, i.e. oral tablets and testing non-smokers
showed that nicotine produced improvements on the classic Stroop test in nonsmokers (Wesnes & Warburton, 1978). Increments in performance of non-smokers
were also found on a vigilance task (Wesnes et al., 1983) and on a rapid information
processing task (Wesnes, & Warburton, 1984). Both studies used the same route of
nicotine delivery, i.e. oral tablets.
In a more recent study Foulds et ll. (1996) utilized a subcutaneous route of
nicotine delivery to 18 abstaining smokers and 18 never-smokers. Each subject
received two injections (40 min apart) of saline, 0.3 mg nicotine, or 0.6 mg nicotine in
a balanced order over three sessions. Performance was assessed before and after the
injections on nine tests: news recall, Sternberg memory task, finger tapping, logical
reasoning, rapid visual information processing (RVIP), long-term word recognition,
digit recall, Stroop test, and critical flicker fusion threshold.
In the news recall task subjects were required to write down a short story as
accurately as possible immediately after its presentation and again upon the
completion of other tests. In the Sternberg memory' task subjects had to identify as
quickly and as accurately as possible on a series of trials whether a single digit that
appeared on the computer screen (probe digits) was a member of the set of digits
presented earlier (memory set). Finger tapping involved computer space bar pressing
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for 200 taps as quickly as possible using the first finger on the dominant hand. Logical
reasoning was represented with two letter configurations (A and B), which involved
vertical positioning of either of the letters on top of each other followed by a
statement describing a particular configuration. For example, subjects may have been
presented with “A is above B” and were required to respond appropriately to the
veracity of each statement. Both the number of correct responses and the reaction time
were analyzed.
The RVIP task required subjects to respond accurately and swiftly to each
occurrence of three consecutive odd or even digits presented throughout a series of
digits appearing on the computer screen over a period of 10 min at a rate of 100 digits
per minute. In the long-term word recognition task, each participant was presented
with a list of 16 words of similar length and frequency of occurrence. Their
subsequent recognition in a larger list of 32 words was assessed after a delay of 24
minutes since the presentation of the original list. After studying each word for 2
seconds the participants were relegated to complete the RVIP task, which took
approximately 24 minutes. The digit recall task was given as a series of nine digits
randomly organized in a row across the center of the screen for 1 second. After a 3
second retention interval eight of the originally presented digits appeared on the
screen again but in a different order, and the subject’s task was to identify the missing
digit. Both accuracy and reaction time were analyzed.
The classic Stroop test consisted of a series of words presented in either red,
green, or blue colors. Among the words the names of the colors proper (red, green,
and blue) were also present. Sometimes, these names corresponded to the colors they
denoted (congruent) but sometimes they did not (incongruent). The researchers
measured the difference in response time and accuracy of identification of the color of
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congruent and incongruent words. Finally, the critical flicker fusion threshold task
(CFFT) was given as a measure of central nervous system arousal rather than
cognitive performance (Clark et al. 1963). Subjects were presented with four lights at
a distance of lm. One of the lights flashed and the subject had to guess which one it
was. The flicker frequency was adjusted incrementally until the highest frequency at
which the subject could identify the flickering light on four out of four trials (the
CFFT).
The findings indicated significantly faster correct responses in the abstinent
smokers on the logical reasoning test with 0.3mg and 0.6 mg producing an
improvement in correct reaction times by 7% and 9%, respectively. The overall
average of correct responses on the logical reasoning test was 90%. In the smokers’
group the 0.6 mg doses produced a 20% increase in the number of correct responses
and a 10% improvement in reaction time on the RVIP task, and more correct
responses (+16%) and sensitivity (+18%) on the word recognition task. There was no
effect at either dose on the digit recall, Stroop or critical flicker fusion tasks.
In non-smokers nicotine produced faster reaction times on the RVIP (12%
improvement) in the 0.6mg dose. Unlike in smokers, there was a clear improvement
in digit recall correct reaction times (18% and 21% for 0.3mg and 0.6mg,
respectively), but this appeared to be at the expense of correct responses (-28% and 32%). Although an earlier study by Provost and Woodward (1991) reported that
nicotine increased the speed of naming color of incongruous color-word stimuli in the
Stroop test, the researchers didn’t find significant difference between the two groups
in both the nicotine and the saline condition on the above task. No evidence was
found for an effect of nicotine on recall of news stories (in both immediate and
delayed recall conditions). There was also no effect of nicotine on the Sternberg task.
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More recent studies focused on the use of a transdermal nicotine patch as the
primary nicotine delivery system. In these studies the most consistent finding of
nicotine effects on human cognition is an improvement in vigilance and information
processing. For example, Warburton and Mancuso (1998) attempted to examine the
effects of nicotine delivered via a transdermal patch (21 mg/day) on the performance
of smokers on a variety of cognitive tasks including those of attention and memory.
The use of a 21 mg nicotine patch with sustained transdermal release of nicotine
enabled the researchers to control possible confounding variables associated with
cigarette use such as puffing and inhalation strategies. Moreover, the patch as a
measured delivery system, improved the effectiveness of placebo control due to the
fact that an effective placebo tobacco cigarette is limited in reducing the likelihood of
the participant, or experimenter, or both to be oblivious of the nature of the treatment
(a double-blind design). It has been shown that subjects can consistently tell the
difference between a denicotinized or herbal placebo and a nicotine-containing
cigarette (Heishman et al., 1994).
It was previously established that 6 hours after the activation of the patch a
21 mg dose produced average levels of nicotine similar to trough levels, which are
found in a smoker on an average smoking day, i.e. about half of the peak levels
achieved at the end of each cigarette (Benowitz et al., 1991). Stable isotope analysis
of transdermal nicotine absorption also showed that the maximum rate of absorption
occurs between 6 and 12 hours after the activation of the patch. Unlike cigarette
smoking, which results in rapid delivery of nicotine to the bloodstream, transdermal
nicotine systems result in a different blood concentration - time profile, without the
peaks and troughs characteristic of cigarette smoking. (Benowitz et al., 1991).
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In their experiment Warburton and Mancuso (1998) used four types of tests:
attention testing, memory tests, problem solving and mood assessment. Attentional
testing was done using the RVIP task. Memory testing comprised verbal memory
assessed in a recall task of a list of 72 words in both immediate and delayed (at the
end of the session) conditions as well as nonverbal memory, which was examined
with a non-verbal test battery. The battery included tests of pattern recognition,
memory for spatial location, and a test of visuo-spatial memory. The tasks made use
of touch sensitive screens, with participants indicating their selection by touching the
appropriate item or position on the screen. Froblem solving skills were studied using
the Semantic Verification Task (Baddeley, 1968), which is similar to the logical
reasoning task used by Foulds et al. (1996). This task involves a sentence describing
the order of two letters (e.g. A follows B). Upon the presentation of these two-letter
sequences participants are asked to assess the veracity of the statement concerning the
sequence of the presented letters by either saying “yes” or “no”.
The results indicated improved attentional performance (by 11%) in the
nicotine condition showing a significantly greater number of correct responses, and
significantly shorter reaction times (by 4%). On the measures of memoiy improved
immediate and delayed recall were also observed in the nicotine condition but no
significant differences were found for either of the measures of nonverbal memory.
Modulation of mood was also noted in the nicotine condition characterized by
significantly greater feelings of relaxation and calmness. Unlike Foulds et al. (1996),
however, the researchers did not find any effect of nicotine on either the number of
correct responses or reaction time on the Semantic Verification Test (Warburton et al.,
1998).
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In a subsequent study Mancuso and Warburton (1999) used a 21 mg nicotine
patch to assess performance of 24 heavy smokers (over 15 cigarettes / day) on a
battery of cognitive measures that included the Random Letter Generation test, the
classic Stroop task, and the Flexibility of Attention test. These instruments were
chosen in an attempt to isolate specific effects of nicotine on attention si nce these tests
are thought to measure different types of attention (Mancuso & Warburton, 1999). On
the basis of the Heishman et al. (1994) review of the studies evaluating effects of
nicotine on attention, Mancuso and Warburton (1999) hypothesized that a strong
positive effect of nicotine would be observed on tests measuring intensity of attention
rather than selectivity and explained that intensity is involved in tasks requiring
energetic attentional resources or effort such as vigilance tests (e.g. CPT, RVIP)
which primarily measure sustained attention. On the contrary, the researchers
suggested that increments in performance attributed to nicotine would be less
observable on tasks involving selectivity such as those measuring focused attention
(e.g. choice reaction time tests), selective attention or divided attention.
Specifically, the Random Letter Generation task was used to assess the
intensity component of attention. In this test participants were asked to produce
random sequences of letter-names and to avoid letter repetitions or stereotypical letter
strings either alphabetical (e.g.abc) or acronyms (e.g. BBC). While avoidance of
diagram repetitions (first order redundancy) is meant to exceed the capacity of the
working memory' monitoring letter pairs, suppression of stereotypical responses is
thought to reflect inhibition of overleamed routines. The classic Stroop task was used
to assess both the intensity of attention by measuring the speed of naming of the color
patches and the selectivity' of attention by testing the interference of color words with
naming the color of the ink. Finally, the Flexibility of Attention test was included
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into the battery to measure the selectivity of attention by assessing both the ability to
focus a target and to shift this focus from target to target depending upon tiie
requirements of the task. In this test one letter and one number were presented
simultaneously and in random order on a computer screen either to the left or to the
right from a fixation point. The participants were asked to press a corresponding
computei Key as soon as they detected the side on which the letter appeared. At a
signal the participants were also asked to switch to monitoring numbers and to
similarly respond with the depression of a computer key once the side of the target
had been detected.
The volunteers were subdivided into two groups. One group was tested 3
hours after the application of the patch while the other group wore the patch for 6
hours. For each group a crossover design was used so that each group was tested
twice either in the nicotine or in the placebo condition with a 1- week interval
between the sessions. The researchers found no differences in performance between
the nicotine and the placebo conditions on any of the tests after three hours of patch
application. However, after 6 hours nicotine-treated participants were significantly
less redundant on the Random Generation test than in the placebo condition, which
corresponded to the enhancement of the intensity component of attention.
The participants in the nicotine condition completed the Stroop task
significantly faster both in the control condition and in the interference condition
following the 6-hour patch application. Since response latencies were reduced in both
conditions significant Stroop interference was not found, and the researchers
concluded that nicotine improved performance by increasing intensity of the
attentional effort rather than enhancing attentional selectivity. Consistent with their
research hypothesis no significant improvement was observed in the nicotine
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condition on the Flexibility of Attention test measuring selectivity, in which both
reaction time and the number of correct detections did not significantly differ between
the treatment conditions.
Performance of non-ADHD non-smokers on a variety of affective and
cognitive measures after administration of a transdermal nicotine patch has also been
examined. In a study by Levin et al., (1998) participants were assigned to either a 7mg
of nicotine condition or to a placebo condition in a counterbalanced double-blind
manner. Treatment measures were taken 3 hours and 10 minutes after the application
of the patch. The results indicated that nicotine significantly increased self-perceived
vigor as measured by the Profile of Mood States (POMS) (McNair, Lorr, &
Droppleman, 1981). The POMS was designed for subjects' self-report and consisted
of a list of adjectives describing mood state and included vigor, tension, depression,
anger, fatigue, and difficulty concentrating. The researchers also used Conner's
(1995) computerized Continuous Performance Test (CPT) to assess subjects'
attentiveness. The results indicated that nicotine significantly decreased the number of
errors of omission (fewer misses) without causing increases in either errors of
commission (false alarms) or correct hit reaction time. Nicotine also significantly
decreased the variability in hit reaction time. The researchers concluded that nicotine
administered via transdermal patches could improve attentiveness in normal adult
non-smokers.
Nicotine and ADHD
Despite a variety of studies examining cognitive effects of nicotine and in
spite of a suggested link between nicotine and ADHD, relatively little work has been
done investigating its impact on cognitive performance of adults with ADHD.
Nevertheless, there is preliminary evidence of improved attention along with other
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changes on a number of response characteristics that have been reported in previous
studies.
In the first study to directly examine the effect of nicotine on adults with
ADHD (Conners et al., 1996) the researchers administered nicotine via a patch to both
smokers (n = 6) and non-smokers (n= 11) (21 mg and 7mg respectively). Smokers were
required to abstain from tobacco use for 12 hours prior to testing. This requirement
was confirmed on the day of testing with an end-tidal CO measure. This measure
provides a simple non-invasive breath test that has been proven to accurately correlate
to the levels of carboxyhemoglobin (COHb) found in the blood of a person after
smoking a cigarette (Warbuton, et al., 1998). The CO reading appears either in parts
per million carbon monoxide to air (CO-PPM) or percentage carbon monoxide to
hemoglobin (%COHb).
Participants were randomly assigned to either nicotine-placebo or placebonicotine sequence. Thus each subject served as his / her own control and was treated
with a corresponding patch on two consecutive days. Participant testing took place 3
hours after the placement of the patch and included a series of self-report and
computerized assessment procedures. Thus childhood symptoms of ADHD were
evaluated with the Wender Scale (Wender, 1995). The researchers also assessed three
personality dimensions of the participants (novelty-seeking, harm-avoidance, and
reward dependency) using a Tripartite Personality Questionnaire (Cloninger, 1991).
The POMS was administered as a measure of current mood state rated for the
preceding week. Psychological symptoms experienced on the day of testing were
evaluated with the Hamilton Depression Scale (Hamilton, 1960) and the Symptom
Checklist- 90 (Derogatis, 1983). Assessment of the treatment response was conducted
by using a modified Clinical Global Impression scale (CGI) (NIMH, 1985). This is a
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7-point scale that has been widely used in clinical studies in which higher scores
correspond to a more severe clinical condition. Smokers were also asked to complete
the Fagerstrom Test of Nicotine Dependency (Fagerstrom, 1989), a 6-item
questionnaire used to determine the degree of one's cigarette dependence. Accuracy in
judging a time interval was also measured in non-smokers using the Peak-Interval
Timing Procedure (Meek & Church, 1987). Computerized measures included the
Conners' Continuous Performance Test (CPT) (Conners, 1994) and a computerized
version of the classic Stroop Task (Neurosoft, 1990).
The results demonstrated clear improvement in the speed of response (RT) and
ability to sustain attention (reduced variability across trials) were shown on the CPT
task. The mean error rate was about 33%, which closely matched the norm for nonADHD adults on that test. On the basis of these findings the researchers suggested
that impulsive action could be less of a problem for adults with ADHD than
limitations in attention and concentration. On the POMS measure, the participants
also reported improved vigor and concentration following administration of nicotine,
which were especially apparent in the reports of non-smokers. The results showed that
nicotine administration was associated with more accurate time estimates, which were
also less variable. The researchers, therefore, suggested that adults with ADHD tend
to overestimate the passage of time possibly due to some brain mechanisms involved
with the timing function. In the study the ADHD patients had difficulty determining
when to stop responding, which was partially corrected following nicotine
administration. The researchers proposed a mechanism involving increased
availability of dopamine to timing generators in the brain.
Similar findings were obtained in a subsequent study by Levin et al.(l996). In
this study nicotine was also administered do both smokers (n = 6) and non-smokers (n
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= 11) via a transdermal patch with concentrations of 21mg and 7 mg, respectively.
Both groups served as their own controls (were given a placebo patch) in a
counterbalanced order with 4 days elapsing between each session. The researchers
employed the same measures of attention, mood, childhood symptoms, psychological
symptoms, personality dimensions, treatment response and time estimation that were
used in the original study by Conners et al (1996). In addition the researchers used a
modified version of the Shiffman-Jarvik questionnaire regarding various signs of
nicotine withdrawal. Participant testing took place approximately 3 hours after the
placement of the patch.
The results indicated a significant overall reduction in reaction time (RT) on
the CPT. Smokers also showed a significant reduction in variability of reaction time
measures over trial blocks. The finding of reduced variability indicated a more
consistent attentional focus. Both smokers and non-smokers reported increased vigor
on the POMS scale, but only smokers reported a reduced difficulty concentrating
possibly due to their familiarity with subjective nicotine effects. Nicotine was also
found to improve accuracy of time estimation in both smokers and non-smokers. On
the basis of the obtained results the researchers suggested that observed improvements
could not be attributed to the reversal of withdrawal symptoms in smokers since nonsmokers reported and exhibited improved performance as well. Similarly to the
conclusions of the earlier study the investigators proposed that nicotine alleviates the
disturbance of accurate timing mechanisms in adults with ADHD via its interaction
with dopamine systems in the brain. The researchers also noted that this possible
dopaminergic action of nicotine is similar to that of methylphenidate and
dextroamphitamine used in standard treatment of ADHD. However the researchers
further suggested that since nicotine triggers the release of a number of other
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neurotransmitters this action needs to be further explored in direct comparison studies
with these stimulant drugs.
The proposed comparison has been performed in a recent study examining the
effects of nicotine and methylphenidate on cognitive and subjective measures in nonsmokers diagnosed with ADHD (Levin, Conners, Silva, & March, 2001). In this study
40 ADHD participants (25 males and 15 females) with no comorbid symptoms of
major depression disorder or generalized anxiety disorder have been randomly
assigned to one of the four treatment combinations: control, nicotine only,
methylphenidate only, or nicotine and methylphenidate. A particular treatment
condition was given for 4 weeks. Nicotine was administered via a transdennal patch
that contained 5 mg of nicotine per day during the first and the fourth weeks, and 10
mg of nicotine per day during the second and the third weeks. Methylphenidate
(Ritalin) was given in the form of oral pills in the 20mg per day concentration. This
concentration had previously been effective in the treatment of ADHD in children
(Levin et al., 2001). Dependent variables included clinical, subjective and
computerized assessment measures. Clinical evaluation involved a structured
interview in which the Clinical Global Impression Scale (CGI) scale was used. CGI
measurements were taken during the pretreatment baseline session, after acute drug
administration (Treatment Day 1), and after chronic drug treatment (Treatment Days 8
and 21). Subjective assessment was conducted by using six selected questions from
the POMS battery. The questions concerned such subjective states as tension, fatigue,
vigor, depression, anger, and difficulty concentrating. Finally, participants' cognitive
performance was evaluated at acute and chronic dose test sessions (Days 1 and 21)
with a number of computerized measures which included the Conners CPT, the
simple reaction time, mental spatial rotation reaction time and delayed matching to
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sample. These tests were identical to those employed by Levin et al.(l996) in their
study of the effects of nicotine on cognitive performance in schizophrenic patients
following administration of haloperidol (see discussion above).
The results showed that on the measure of clinical assessment acute
administration of nicotine alone (Dayl) produced significantly lower CGI severity
scores in the treatment group in comparison to the control. Interestingly, the group
that was given methylphenidate showed higher severity scores on the CGI (more
impairment) but not significantly so. Finally, acute administration of both agents
together produced a significantly greater impairment in comparison to the nicotine
group alone. Chronic (Treatment Days 8 and 21) administration of nicotine and
methylphenidate alone and in combined form did not produce significant
improvements on the CGI scale possibly due to improved scores in the placebo
control group.
Only two items (depression and tension) were affected by treatment on the
POMS. Participants showed significant improvement on the question about
depression after chronic (Day 15) administration of nicotine alone and nicotine in
combination with methylphenidate. Methylphenidate administered alone induced a
significant reduction in depression score only on day 21. On the measure of tension a
significant increase (more tense) was recorded following acute (Day 1) administration
of methylphenidate.
No significant effects on either errors of omission or errors of commission on
the CPT were found for either nicotine or methylphenidate administered alone. The
combined treatment group, however, demonstrated the lowest average number of
errors of commission but not significantly different from the control group. Acute
nicotine treatment produced a significant decrease in hit reaction time standard error
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over blocks of the session thus reducing response time variability over the course of
the session. No significant decrease in response reaction time variability was found
for acute methylpenidate treatment. Even after chronic administration
methylphenidate alone failed to induce significant improvement on this measure. The
combined treatment was effective in reducing the variability in hit reaction time over
blocks only after chronic administration. No significant effects were seen on the tests
of simple reaction time, mental spatial rotation and delayed matching to sample. The
researchers concluded that nicotine, especially after acute administration, could be
superior to methylphenidate in alleviating the symptoms of ADHD, depression and
tension and is also more effective in directly combating one of the cognitive deficits
(increased variability in response speed) seen in ADHD which is indicative of
improved attentional consistency.
Although improvements on the measures of the errors of commission on the
CPT and depression on the POMS were observed in the treatment group exposed to
the combination of nicotine and methylphenidate the improvements were not
statistically significant. On the POMS the combined treatment was actually found to
diminish the depression-alleviating effect of nicotine administered alone. Nicotine
might thus possess quite potent therapeutic properties, which can partly account for
the prevalence of cigarette smoking among people with ADHD.
Current Study
It appears that adult ADHD is commonly associated with problems of
attention that are captured by such neuropsychological measures as the CPT (e.g.
Epstein et al., 1998), Stroop, and the WSCT (e.g. Seidman et al., 1997).
Physiologically attentional deficits observed in ADHD have been attributed to
dopaminergic dysfunction (Barkley, 1998) particularly in the prefrontal cortex and
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basal ganglia (Castellanos & Rapoport, 1996). Specifically, overly effective dopamine
transporters have been implicated in the etiology of ADHD as a possible mechanism
of deficient dopamine binding observed in individuals with ADHD (Cook, 1995). At
the same time forty percent of adults diagnosed with the disorder have been reported
using cigarettes regularly in comparison to twenty-six percent of smokers in the
general population (Pomerlau et al., 1996). Nicotine contained in tobacco smoke has
been suggested to be the primary neuroactive element responsible for the prevalence
of cigarette smoking in the ADHD population (Pomerlau et al., 1996). Its neuroactive
effects have been extensively investigated in a variety of studies, and it has been
suggested that its primary action in the brain that might influence both cognitive and
emotive functions involves stimulation of ACh secretion in the cholinergic system
(e.g. Grottick et al., 2000; Jones et al., 1992; Fujii et al., 1999) and facilitation of
dopamine availability in the dopaminergic systems including the nigrostriatal
dopaminergic system (e.g. Levin et al., 1996; Court et al., 1998). Specifically,
nicotine's dopaminergic effects appear to be expressed through the reduction of the
dopamine turnover in the brain (Court et al., 1998), which could thus compensate for
overly rapid dopamine transport back into the presynaptic neuron observed in ADHD
(Barkley, 1998).
Direct behavioral research examining effects of nicotine on cognitive
performance of adults with ADHD showed improved performance on the CPT
following acute nicotine administration (e.g.Conners et al., 1996; Levin et al., 1996).
More extensive research in normal adults has demonstrated differential effects of
nicotine on attention with particularly consistent findings of enhanced performance
observed on measures of sustained attention such as RVIP and CPT (Heishman et al.,
1994). It has been, therefore, suggested that nicotine's ameliorating effect on attention
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most likely stems from its impact on the intensity feature of attention rather than
selectivity which is most observable in tests of vigilance (Mancuso and Warburton,
1999). Moreover, smokers seem to show greater improvement in performance on tests
of attention than non-smokers (Heishman et al., 1994), which might be explained by
their sensitization to nicotine, a situation also observed in rat studies investigating
effects of nicotine on spatial memory (e.g. Grottick et al., 2000). However,
preliminary evidence suggested that non-smokers with ADHD could also show
increased sensitivity to the attentional effects of nicotine due to a possible dysfunction
of dopaminergic transmission (e.g. Conners et al., 1996; Levin et al., 1996).
Furthermore, these attentional effects of nicotine were expected to be
especially prominent on tests that have been demonstrated to be sensitive to both
ADHD and nicotine, i.e. vigilance tests such as CPT. In accordance with the intensity
hypothesis of nicotine's effect on attention other tests of neuropsychological function
such as Stroop and WCST were hypothesized to show more attenuated effects of
nicotine since both measures involve the selectivity feature of attention. Specifically,
the element of intensity measured in the Stroop reflects reaction times in both
conditions and could thus show sensitivity to nicotine without any appreciable
difference in the effect per se. At the same time the WCST is primarily a test of
selective attention and in accordance with the findings of Mancuso and Warburton
(1999) was not expected to reflect attentional enhancement for nicotine.
The present study was, therefore, intended to test the intensity hypothesis of
nicotine effects on attention in adults with attentional deficits (but not necessarily
diagnosed with ADHD) as measured by instruments used for assessment of adults
with ADHD including the Self-Report Rating Scale by McCamey and Anderson
(1996) and the Current Symptoms Scale by Murphy and Barkley (1996). Those
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individuals who scored on the higher end of both scales (more problems with
attention) were compared to those scoring on the lower end (superior attention). Both
groups comprised non-smokers, which was thought to better isolate the effects of
nicotine. It was expected that both nicotine groups would show faster reaction times
and fewer errors on the CPT test and faster response times in both conditions of the
Stroop test than in the placebo condition. No significant differences between placebo
and nicotine conditions were expected for either group on the WCST. Furthermore,
the group with greater attentional deficits was expected to show greater relative
improvement on the CPT and the Stroop than the group with high attention scores.
Additionally, the low attention group was hypothesized to show poorer performance
on all cognitive measures, which was consistent with the selection of these measures
for neuropsychological assessment of ADHD.

CHAPTER II

METHOD
Participants
Participants were selected from the student population of the University of
North Dakota and included 61 male non-smokers over 18 years of age chosen on the
basis of their attention scores on two self-report measures used for the assessment of
ADHD: Self-Report Rating Scale by McCamey and Anderson (1996) and the Current
Symptoms Scale by Barkley and Murphy (1998). According to the DSM-IV criteria
the respondent's score on any of the subscales of the latter instrument is considered to
be clinically significant if at least six out of the nine symptoms listed in each subscale
are marked as 2 (often) or 3 (very often). Barkley and Murphy (1998), however,
contended that the DSM-IV criteria are rather stringent and on the basis of their own
research suggested that four out of nine symptoms answered as 'often' or 'very often'
should be considered clinically significant as it represented the 93rd percentile in the
adult population between ages 17 and 29. Furthermore, the researchers argued that
each of the symptom lists r'or ADHD should be recognized as representing dimensions
of behavior and that a more sensitive scoring approach should utilize all answers to all
of the items. According to this scoring method instead of just counting symptoms
(answered 'often' and 'very often') all items answered 1, 2, or 3 should be summed up
to produce a total score for a given individual. The researchers then recommended
comparing the resultant total score on each of the subscales to the normative values
for a particular age group. Thus, for the group of adults from 17 to 29 years of age a
clinically significant score would constitute +1.5 SD from the mean, which would
57
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result in a score of 13.4 and above. For the purposes of the present study the latter
scoring method seemed to be the most appropriate and consequently, participants'
responses were utilized. Thus an individual demonstrating a total score on the
inattention subscale that exceeded 13 was ascribed to the 'low attention' group while a
score of 6 (mean = 6.3 for adults between 17 and 29; Barkley & Murphy, 1998) and
lower qualified the volunteer for his inclusion into the 'high attention group' (out of 18
items 13 and 5 are equally distant from both ends of the scale). Similarly, a standard
score of 6 or lower on the inattention subscale of the McCamey and Anderson selfreport rating form (1996) was sufficient to assign the respondent to the 'low attention'
group, while a score of 10 or above was required for the participant's inclusion into
the 'high attention' group. If any of the respondents met the inclusion criteria on one
of the instruments but not on the other he was still considered eligible for the
corresponding group assignment.
Exclusion criteria included the following:
1) Elevated blood pressure (greater than 140 /90) on the day of testing, or a history of
hypertension, cardiac disease, cerebrovascular disease and seizures.
2) History of skin problems such as eczema and/or atopic dermatitis, allergies or
sensitivity.
3) Alcohol or other substance abuse including cigarette smoking
4) Use of stimulant or other psychotropic drug treatment
5) Concurrent use of antibiotics, sulfonamides, antihypertensive agents.
Prior to the experiment selected participants had been instructed to abstain from
alcohol ingestion for at least 24 hours before the date of testing, and on the day of
testing participants were also asked to refrain from consuming caffeine-containing
beverages. All consent forms pertaining to the screening of the participants and their
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participation in the study as well as all the treatment procedures implemented in the
study were approved by the University of North Dakota Institutional Review Board.
Materials
A transdermal nicotine patch (NicoDerm CQ) with nicotine concentration of
7mg was used in the study. This concentration is the lowest commercial level of
nicotine available transdermally and was previously safely used with non-smokers
Levin et al. (1998), in which possible side effects of nicotine such as nausea and
dizziness were net observed. A matching placebo patch was represented by a standard
7mg patch without removing its original protective film. In view of the previous
experience with the defective patch the researchers ensured that both halves of the
protective film overlap so that no area of the active side was exposed. To mask the
placebo patch both activated and non-activatcd patches were secured with an adhesive
dcrmntologically-sufc tape completely covering the entire area of the patch and
extending 1cm beyond its edges.
Measures of heart rate and blood pressure were obtained using a Marshall 85
Oscillometric Sphygmomanometer / Electronic Digital Blood Pressure / and Pulse
Monitor.
Subjective Assessment
The Current Symptoms Scale by Barkley and Murphy (1998) was used as one
of the two measures of inattention (reliability and validity of the instrument were not
provided). The scale contained 18 symptom items for ADHD from DSM-IV arranged
in such a way that items pertaining to inattention were odd-numbered and those
pertaining to hyperactive-impulsive symptoms were even-numbered. The items were
rated on a four-point scale (from 0 to 3) with zero indicating 'never or rarely', three
meaning 'very often' and one and two being 'sometimes' and 'often', respectively. The
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scale also contained questions regarding the age of onset of symptoms and areas in
which the client believed that any of the listed problems interfered with his/her ability
to function between ages 5 and 12. Additionally, the scale provided items taken from
DSM-IV for Oppositional Defiant Disorder (ODD), some elements of which along
with symptoms of ADHD had been found to continue into adulthood and contribute to
impairment in interpersonal relations and employment (Barkley and Murphy, 1998).
The second instrument that was used for assessment of attention was a selfreport version rating form by McCamey and Anderson (1996). This questionnaire
contained two sections with the first subscale listing 31 items pertaining to
inattention, and the second subscale assessing the presence of the symptoms of the
hyperactive-impulsive subtype comprising 27 questions. Both sections were rated on
a 5-point scale with zero being 'do not engage in the behavior' and four indicating 'one
to several times per hour' (values one through three evaluate singular or multiple
occurrence of symptoms on a monthly, weekly, and daily basis, respectively).
The instrument showed good test-retest reliability with a Pearson Product
Moment Correlation Coefficient of 0.78 for the inattention subscale (r = 0.77 total
scale; McCamey and Anderson, 1996). The Cronbach's alpha for internal consistency
on the inattention subscale was 0.94 (total scale Cronbach's alpha = 0.98). Content
validity was assured by creating an item pool based on literature review, the DSM-IV
criteria, and the input from psychiatric and psychological personnel (McCamey &
Anderson, 1996). The item/total score correlations for each of the subscales of the
scale were all significant at the 0.001 level. Construct validity was assessed using a
factor analyses, which revealed good separation between the two subscales of the
scale as each cf the subscales correlated with only one factor but r.ot the other
(McCamey & Anderson, 1996).

Neuropsychological Assessment

The Conners CPT was used as a task targeting the intensity feature of attention
and as a diagnostic tool used in the assessment of adults ADHD. This 14-minute task
was presented on an IBM-compatible, Pentium II-processor computer. Participants
were asked to press a keyboard spacebar as quickly as possible in response to any
letter except the letter "X" (probability of occurrence = 0.90) but to refrain from
responding every time the letter "X" (p =0.10) appeared on the screen. Each letter
was displayed for 250 milliseconds over 18 blocks of 20 trials. The signal in each
block was presented at one of the three interval rates, i.e. 1, 2, or 4 seconds in a
counterbalanced order. The dependent measures included hit reaction time, accuracy
(errors of omission and commission), signal detection parameters of d' (sensitivity)
and Beta (response bias) as well as response variability between and within the blocks
(the standard error estimate of hit reaction time).
The Stroop task was used as a test combing both the intensity and the
selectivity features of attention and as a task that had been shown sensitive to both
ADHD and nicotine (Mancuso et al., 1999). This 11-minute task was presented on an
IBM-compatible, Pentium II-processor computer. In this task the participants were
asked to press a color-coded key on the numeric pad of the keyboard corresponding to
the ink color of a color word while ignoring its meaning. Each word or a string of
XXX was presented sequentially in the middle of the screen. In the compatible
condition the color denoted by the word coincided with the ink color, while in the
incompatible condition the ink color of the word was different from its meaning.
Finally, in the control condition a string of colored Xs was substituted for words.
Before the participants could begin the task, they were required to complete a practice
session of ten trials with a minimum of 80% response accuracy. If the results of the
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first practice session were below the required minimum accuracy rate, the practice
block was administered until the desired percentage was obtained. Upon completion
of the test response latencies for each condition measured in milliseconds were
automatically generated along with percent correct scores on each measure. The
difference in the speed of response between the incompatible color and control
conditions was considered as interference while the difference between reaction times
in the compatible and control conditions was regarded as facilitation (McLeod, 1991).
Finally, the Wisconsin Card Sort Test was be used as a measure of the
selectivity feature of attention and as an instrument shown to reflect cognitive
impairments of ADHD adults (Seidman et al., 1997). On this task the participants
were presented with a pack of 60 cards, each displaying one or more symbols
represented by one of four shapes (triangle, star, cross, or circle) in one of four colors
(red, green, yellow, or blue). The participants were instructed to place cards
sequentially below four key cards but were not told the rule according to which the
sorting should be performed. The experimenter verbally reinforced the participants for
implementing a correct sorting strategy, on which they arrived by trial and error. The
sorting order that was required for a participant to complete proceeded from color to
form, and then number. Once the participant deduced the correct strategy and
correctly placed 10 consecutive cards the rule was changed again and the participant
had to find the next correct strategy. The WCST dependent measures included
number of trials administered, trials to complete the first category (the number of
trials to make 10 consecutive correct responses), total number of categories achieved,
total number/percentage correct, failure to maintain set (interruption of the correct
sorting strategy after five consecutive correct responses has been made), perseverative
errors / responses (responses that would have been correct under the previous sorting
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rule) and their corresponding percentages, total number of errors, total number of
correct trials, conceptual level responses (consecutive correct responses occurring in
runs of three or more), and 'learning to learn' (mean overall difference in the
percentage of errors calculated for each completed category).
Procedure
Potential participants were screened for the presence of attention problems
and/or superior attention using the Current Symptoms Scale (Barkley and Murphy,
1998) and the Self-Report Rating Form by McCamey and Anderson (1996) during
regular psychology lab classes. On the basis of their scores on the above measures
selected individuals were be assigned to either a low-attention group or a highattention group. Both groups were further randomly subdivided into placebo and
nicotine groups thus rendering four groups with 16 individuals in both low attention
groups, 16 individuals in the high attention nicotine group and 14 participants in the
high attention placebo group. Each participant was treated individually in the
laboratory premises of the Psychology Department of the University of North Dakota.
Thus on the treatment day each participant received either a placebo (Omg) or a 7mgof- nicotine patch depending upon his group assignment.
The day prior to the experimental session all participants were instructed to
receive their normal amount of sleep and to abstain from caffeine for at least 12 hours
prior to reporting to the lab. Additionally, they were asked to refrain from alcohol
ingestion for at least 24 hours prior to the administration of the patch. Upon arrival at
the lab each participant had his blood pressure taken by a trained research assistant.
Those with blood pressure of 140/90 or higher (2 students) were dismissed from the
study. Once an individual was found eligible for participation he was instructed to
carefully read and sign a consent form.
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Individual participation was terminated at any point during the study if so
desired by the participant without any prejudice against him on part of the
experimenter. Thus four participants undergoing nicotine treatment were dismissed
either after 5-6 hours of participation or during testing (7th hour) due to complaints of
somatic distress such as nausea, dizziness, upset stomach, and agitation although
measures of blood pressure and heart rate were within normal limits (< 140/90). Once
dismissed the participants were followed up with a phone call several hours later to
ensure their return to normal functioning. All of the excused participants reported
feeling much better at that point and no additional contact with these individuals was
further attempted.
A transdermal patch was applied to the left upper arm of the participant. The
participants remained in the lab for 6 hours, during which time they were free to
engage in an activity of their choosing (e.g. reading, using a computer, watching a
movie). At least 2 hours after patch application but not later than 4 hours since their
arrival to the lab, participants were allowed to take a one-hour lunch break and were
instructed not to have any caffeine-containing products. During the first two hours
blood pressure was monitored at 30- minute intervals and every hour afterwards.
After 6 hours testing sessions began. To control for possible order effects (e.g.
fatigue, carry over etc), the neuropsychological measures were administered in a
counterbalanced order.
Research Design and Statistical Analysis
The design of the study included two between -subject factors of group (low
attention x high attention), and treatment (placebo x nicotine). A 2 (groups) x 2
(treatment) x 3 (time) mixed analysis of variance was performed on systolic and
diastolic blood pressure, and heart rate with "time" being a within-subject factor
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having 3 levels ((initial measurement before patch application, 6 hours after a patch
has been applied (before the testing session), and final post-test measurement)). Each
dependent measure on the CPT task was separately analyzed with a 2 (group) x 2
(treatment) x analysis of variance. On the classic Stroop a 2 (group) x 2 (treatment) x
3 (condition) mixed ANOVA was performed with "condition" (congruent, control,
and incongruent) representing a within-subject factor. Each dependent measure on the
WCST was separately analyzed with a 2 (group) x 2 (treatment) ANOVA. Significant
effects were followed up with the Tukey's test of pairwise comparisons.

CHAPTER III

RESULTS
Individual Differences
Individual differences between the four groups were assessed with a series of
2 (group) x 2 (dose) analyses of variance (ANOVAs). The means and standard
deviations are given in Table 1 as a function of group membership and experimental
treatment. The results did not show any significant age differences among the groups.
Consistent with the selection criteria for assigning participants to low and high
attention groups, the main effect of group was found on both measures of attention:
the Current Symptoms Scale by Barkley and Murphy, F (1, 59) =102.795, g<.01, and
Self-Report Rating Scale by McCamey and Anderson, F (1, 60)= 10.196, p<.01.
Table 1. Means and Standard Deviations (SD) for Individual Difference Variables as
a Function of Dose and Group.

7mg

Placebo

14

18

3

Placebo

OQ

High

Low

16

N

16

Age

20.06 (3.86)

21.00 (4.52)

19.86 (.95)

20.31 (1.78)

Barkley

10.47 (3.46)

10.55 (3.91)

2.14(2.07)

3.75 (1.39)

McCamey

5.75 (1.44)

4.50 (2.66)

12.43 (2.21)

17.81 (4.65)
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Physiological Measures
A 2 (groups) x 2 (dose) x 3 (time) mixed analysis of variance was performed
on systolic and diastolic blood pressure, and heart rate with time being a withinsubject factor. The 3 time periods that were compared in the analysis were: Time 1
(baseline), Time 2 (after 6 hours of patch application prior to testing), Time 3 (final
measurement, immediately after testing (7 hours after patch application)). The results
did not show any significant differences among the groups on the above measures at
any of the time periods irrespective of nicotine treatment. Corresponding means and
standard deviations are provided in Tables 2, 3, and 4, respectively.
Table 2. Means and Standard Deviations (SD) for Systolic Blood Pressure over Time
as a Function of Dose and Group.
Time 1

Time 2

122.65 (10.22)

123.53 (13.74)

120.11 (8.33)

Nicotine

110.81 (26.52)

117.97 (8.67)

120.86 (8.36)

Placebo

116.43 (14.77)

122.07 (9.59)

119.46 (10.36)

119.00 (7.49)

124.22 (8.06)

120.81 (14.42)

Placebo

Time 3

Low Attn.

High Attn
Nicotine

Stroop Task
Data from the Stroop task were analyzed with a 2 (group) x 2 (dose) x 3
(condition) Mixed Analysis of Variance, in which reaction time and percent correct
were treated as dependent measures and condition was used as a within- subject factor
with three levels: congruent, control, and incongruent (see tables 5, and 6 for
corresponding means and standard deviations).
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Table 1L Means and Standard Deviations (SD) for Diastolic Blood Pressure over Time
as a Function of Dose and Group.
N
Placebo

(14)

Time 1

Time 2

Time 3

72.61 (10.66)

69.47 (8.08)

71.14 (8.43)

Low Attn.
(18)

Nicotine

67.41 (8.08)

66.09 (7.44)

67.81 (8.59)

(14)

Placebo

71.57 (11.86)

69.04 (6.23)

72.14 (9.26)

71.72 (8.52)

73.47 (8.89)

69.41 (7.38)

High Attn
(16)

Nicotine

Table 4. Means and Standard Deviations (SD) for Heart Rate over Time
as a Function of Dose and Group.
N
(14)

Placebo

Time 1

Time 2

Time 3

75.36 (8.96)

70.32 (10.93)

70.82 (10.78)

Low Attn.
(is)

:

Nicotine

67.61 (9.15)

72 89(14.75)

71.81 (9.64)

(14)

Placebo

69.50 (8.98)

71.82(10.73)

69.96 ( 10.15)

66.50 (9.76)

67.88 (21.22)

72.63 (111.99)

High Attn
(16)

1Nicotine

A significant main effect of condition was found for reaction time, F (2, 114)
=117.42, g<.01. A follow-up Tukey test of pairwise comparisons showed that th '
participants responded significantly faster in the control condition (M=782.35 ms) of
the task than in the incongraent condition (M=906.150 ms), indicating an effect of
interference (Stroop effect). A similar facilitation effect in the congruent condition
was not observed (M=807.646 ms).
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Table 5. Means and Standard Deviations (SD) for Reaction Time in the Three
Conditions of the Stroop task as a Function of Dose and Group.
N
(16)

Placebo

Congruent

Control

Incongruent

773.50 (96.54)

760.38 (76.75)

889.0'6 (130.47)

Low Attn.
(16)

Nicotine

792.25 (188.05)

791.75 (166.82)

910.6'9 (223.76)

(13)

Placebo

736.92 (101.39)

738.85 (116.21)

850.5-4(111.02)

839.00 (168.08)

838.44 (151.83)

974.3 1 (192.76)

High Attn
(16)

Nicotine

Table 6. Means and Standard Deviations (SD) for Percent Correct in the Three
Conditions of the Stroop Task as a Function of Dose and Group.
N
(16)

Placebo

Congruent

Control

Incongruent

98.96 (1.72)

98.61 (2.27)

97.74 (2.73)

Low Attn.
(16)

Nicotine

98.61 (2.27)

98.61 (2.03)

96.87 (3.50)

(13)

Placebo

98.93 (1.81)

98.93 (1.41)

97.65 (2.74)

98.78 (2.48)

98.96(1.72)

98.84(1.98)

High / Vttn
(16)

Nicotine

A significant main effect of condition was found for percent correct, F (2, 114)
=5.99, p=.003. A follow up Tukey revealed that the participants were more accurate
in identifying the color of a control word (M=98.78) than that of an incongruent word
(M=97.78). A similar comparison between the accuracy rate in the control condition
and that of the congruent condition (M=98.82) was not significant.
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Neither group membership, nor administration of nicotine were found to
produce significant differences on the measures of reaction time and response
accuracy.
Conner's CPT
A series of 2 (group) x 2 (dose) ANOVAs were conducted for each of the
dependent variables on the Conner's CPT. The variables included the number of
omissions, number of commissions, reaction time for correct responses (hit RT), hi
reaction time standard error (overall response speed consistency), variability (the
amount of variability the individual shows in 18 separate segments of the test in
relation to his own overall standard error), detectability (d'; individual discriminative
power), response style (Beta; conservative or liberal), perseverations (reaction time
that is less than 100ms), hi* reaction time block change (change in reaction time
across the blocks of the test), hit standard error block change (change in response
consistency over blocks), hit reaction time interstimulus interval (ISI) change (change
in average reaction times at the different Inter-Stimulus Intervals), and hit standard
error ISI change (change in the standard error of reaction times at the different InterStimulus Intervals). Corresponding means and standard deviations are displayed in
Table 7.
An effect of dose approaching statistical significance, F_(l, 59)=3.742, p=.058,
was found for the number of commissions. The size of the effect was moderate in the
sample (r|2= 0.06) but small when estimated for the population (co2= 0.01; Cohen,
1977). A visual inspection of the plotted scores for that variable revealed a somewhat
positively skewed distribution. The degree of skewness, however, was not statistically
significam (Fisher skewness coefficient = 1.76, p>0.05). Nevertheless, there was a
potential for discrepancies among the group variances as the obtained ratio of the
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largest (sf high, nicotine = 90.44) to smallest (sf low, placebo = 37.08) variance was
greater than 2 to 1, which in the case of unequal group numbers might indicate
possible pioblems with the original F test, warranting a data transformation (Myers &
Weil, 1995). Since the da,a were collected in the form of frequency counts, a square
root transformation was deemed appropriate (Myers & Well, 1995). The analysis of
transformed scores for the number of commissions resulted in a statistically
significant main effect of dose F_(l, 59)=4.03, p=.049, indicating fewer errors of
commission in the 7mg-of~nicotine condition than in the placebo condition ( M=3.248
vs. M=3.793, respectively).
Table 7. Means and Standard Deviations (SD) for Dependent Variables on the
Conner's CPT.
High Attn.

Low Attn.
Placebo

16

N

7mg

7mg

Placebo

17

16

14
94 (3.19) 3.57 (4.23)
12(6.25) 13.43 (8.46)

Omissions
Commis.

6.38 (13.70)
17.56 (6.10)

I.
II.

Hit RT (ms)
Hit RT SE
Variability

313.66 (40.89)
4.65 (1.64)
7.47 (6.44)

318.31 (79.49) 340.33 (45.02)
5.38 (1.67)
4.65 (1.93)
7.80 (6.00)
6.6 (5.91)

1.94(1.84)
12.38(9.51)
368.85 (92.17)
5.63 (2.76)
7.58(5.11)

Detectability .46 (.22)
Resp. Style .53 (.34)
Persev.
1.75 (2.98)

.84 (.33)
.69 (.45)
.41 (.80)

.76 (.52)
.57 (.51)
1.07 (1.73)

.77 (.40)
.93 (.84)
.31 (.79)

Hit RT Block
Hit SE Block
Hit RT ISI
Hit SE ISI

.018 (.064)
-.017 (.064)
.053 (.062)
-.006 (.10)

-.007 (.03)
.007 (.10)
.06 (.05)
.00 (.10)

.00 (.37)
-.01 (.08)
5.00 (.05)
.01 (.13)

00 (.00)
-.006 (.077)
.056 (.051)
-.031 (.06)

The analysis also showed a significant main effect of group for hit reaction
time, F_(l, 59)=4.92, g-.03, with participants in the low attention group displaying
faster hit reaction times than those in the high attention group (M=315.987 vs.
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M=li 54.59, respectively). The size of the effect was in the moderate range for the
sample (r|2= 0.08) but very small when calculated for the population (co2= 0.003).
Although the distribution of scores on that variable did not appear to deviate from
normality (Fisher skewnesss coefficient = 0.74, p > 0.05), an examination of group
variances revealed a ratio of the largest (sf high, nicotine =8,493.47) to smallest
variance (sf low, placebo = 1,671.99) of 5 to 1 indicating a potential violation of the
heterogeneity of variance assumption of ANOVA, thus warranting a data
transformation (Myers & Well, 1995). Since the data concerned reaction times, a
logarithmic transformation of the raw scores was deemed appropriate (Myers & Well,
1995). A subsequent analysis of the transformed scores did not indicate a significant
difference between the groups on the measure of hit reaction time, F (1, 59/= 2.87,
p-096.
An effect of dose approaching statistical significance was observed on the
measure of detectability, F_(l, 59).= 3.87, p=.054, with individuals in the 7mg-ofnicotine condition showing better ability in discriminating between the stimulus letter
("X") and non-X stimuli (M=80 vs. M=.61). 'ihe size of the effect was moderate in
the experimental sample (r|2= 0.06) but small when estimated for the population (co2=
0. 01).
A main effect of dose was also found for the number of perseverations, F (1,
59) =5.31, p=.025. The size of the effect was moderate in the sample (r|2= 0.08) but
smaller in the population (co2= 0.05). Perseverations were defined as any reaction time
that was less than 100 ms (Conners, 1994). Based on the knowledge of a normal
physiological ability to respond, such responses were considered to be either slow
responses to a previous stimulus, a random response, an anticipatory response, or a
response repeated without any assessment of the stimulus or task requirements.
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Participants in the placebo condition performed a significantly greater number of
perseverations (M=1.41) than those treated with 7mg of nicotine (M=-36).
No significant differences for either group or dose were found on measures of
omission, standard error of hit reaction time, variability, response style (Beta), hit
reaction time block change, hit standard error block change, hit reaction time ISI
change, and hit standard error ISI change. None of the group x dose interactions were
significant.
Wisconsin Card Sorting Test
The assessment of performance on the Wisconsin Card Sorting test (WCST)
was made on 16 measures computed from performance on the task. The scores on
each measure were analyzed separately with a series of 2 (group) x 2 (dose)
ANOVAs. The variables included number of trials administered, total number correct,
total number of errors, percent errors, perseverative responses, percent perseverative
responses, perseverative errors, percent perseverative errors, non-perseverative errors,
percent non-perseverative errors, conceptual level responses (CLR), percent
conceptual level responses, number of categories completed, trials to complete first
category, failure to maintain set, and learning to learn. Corresponding means and
standard deviations are presented in Table 8.
A significant main effect of group was observed for the number of categories
completed, F (1, 56) =4.14, p=.047 indicating completion of fewer categories by the
participants in the high attention group (M=5.32) than the number completed by their
counterparts in the low attention group (M=5.87). The size of the effect was moderate
in the experimental sample (r)J= 0.07) and small in the population (co2= 0.01). A
visual inspection of the plotted scores for that variable revealed a negatively skewed
distribution, that was significant at a=0.01 level, Fisher skewness coefficient = -8.37).
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Table 8. Means and Standard Deviations (SD) for Dependent Variables on WCST.
Low Attn.
Placebo
N

16

High Attn.
7mg
15

Placebo

7mg

14

15

# Trials

88.75 (15.71)

88.00 (18.74)

93.57 (24.00)

99.93 (24.26)

# Correct

71.00 (6.55)

70.00 (8.16)

71.36 (11.35)

72.67 (7.36)

# Errors

17.67(10.10)

18.20(13.52)

22.29(18.22)

27.27(19.02)

% Errors;

19.31 (6.73)

18.53 (9.09)

21.14(12.26)

24.47(12.43)

Prsv. R.

10.38 (6.04)

9.20 (7.00)

10.86 (8.24)

14.53 (9.88)

% Prsv. R.

11.06(4.67)

9.53 (5.18)

10.78 (5.70)

13.40 (6.64)

Prsv. Err

9.63 (5.44)

9.07 (6.94)

10.43 (7.38)

13.80 (8.96)

% Prsv. E.

10.38 (4.06)

9.40 (5.11)

10.36 (4.83)

12.73 (5.85)

Nonprsv., E.

8.06 (5.78)

9.13 (6.93)

12.00(12.20)

13.80(11.99)

% Nonprsv. E 8.44 (4.49)

9.53 (5.19)

11.07 (8.77)

12.07 (8.77)

CLR

65.25 (4.30)

64.60 (9.61)

64.86(11.39)

62.80 (8.28)

% CLR

74.94 (8.83)

75.60 (13.87)

72.64 (16.71)

66.73 (18.13)

# Categories 6.00 (.00)

5.73 (1.03)

5.64 (.93)

5.00(1.56)

Trials to 1st

11.00 (.73)

12.93 (5.01)

20.43 (19.14)

16.13 (16.86)

Fail M. Slet

.44 (.51)

.53 (.92)

1.00 (1.52)

1.20(1.21)

Lm. to Lm.

-5.59 (17.53)

-2.71 (6.87)

9.35 (26.56)

-9.78 (19.24)

Additionally, there was a potential for discrepancies among the group
variances as the ratio of largest group (sf high, nicotine = 2.43) to smallest (sf low,
placebo = 0.00) variance was greater than 2 to 1, which in the case of unequal group
numbers might indicate possible problems with the original F test, warranting a data

75

transformation (Myers & Well, 1995). Since the data were collected in the form of
frequency counts, a square root transformation was deemed appropriate (Myers &
Well, 1995). The analysis of the transformed scores showed only marginal
significance of group on that measure, F_(l, 56)=3.76, p=.058).
Similarly, although a significant moderate (r|2= 0.07) main effect of group was
found for the variable 'failure to maintain set', F (1, 56)=4.79, p=.033), a visual
inspection of the plotted scores for that variable revealed a positively skewed
distribution. The degree of skewness was significant at oc=0.01 with Fisher skewness
coefficient of 5.22. Additionally, there was a potential for discrepancies among the
group variances as the ratio of the largest (sf high, placebo = 2.31) to smallest (sf low,
placebo = 0.26) variance was greater than 8 to 1, which could indicate possible
problems with the original F test, warranting a data transformation (Myers & Well,
1995). Since the data were collected in the form of frequency counts, a square root
transformation was conducted (Myers & Well, 1995). The analysis of transformed
scores did not show any significant differences between the two attention groups on
the above measure, F (1, 56)=3.48, p=.067.
A significant group by dose interaction was found for the variable 'learning to
learn', F (1, 56) =5.01, p = .029. The interaction was robust showing a moderate effect
size in the experimental sample (r|2= 0.08) that retained its medium size when
generalized to the population(co2= 0.06). Learning to learn was defined as the
participant's average change in conceptual efficiency across consecutive categories of
the WCST. A positive learning to learn score reflects improved ability of a participant
to deduce a correct sorting strategy across consecutive categories, which is presumed
to be due to learning.
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A follow-up Tukey analysis of pairwise comparisons revealed that the
participants in the high attention group who had been treated with a 7mg mcotine
patch showed a significantly lower average learning to-leam score (M=-9.78) than
their group peers in the placebo condition (M=5 35). No significant differences
between placebo and nicotine conditions on the above measure were noted in the low
attention group, although individuals treated with 7mg of nicotine did show somewhat
better learning scores (M=-2.71) than their placebo counterparts (M=-5.59). Finally,
the placebo condition in the high attentiveness group was associated with significantly
better learning scores (M=9.35) than those demonstrated in the same treatment
condition by the participants in the low attention group (M=~5.59).
No significant effects of either group or dose were found for the number of
trials, total number of correct responses, total number of errors, percent of errors,
number of perseverative responses, percent of perseverative responses, number of
perseverative errors, percent of perceverative errors, number of non-perseverative
eiTors, percent of non-perseverative errors, number of conceptual level responses,
percent of conceptual level responses, or the number of trials to complete the first
category. None of the interactions for the above variables showed statistically
significant differences among the groups.
Analysis of Covariance (ANCOVA)
Although there were no significant age differences found among the four
groups, the Wisconsin Card Sorting Test is a measure sensitive to age (Heaton et ai.,
1993). Specifically, increments in performance have been observed from 5 years
through 19 years of age with a subsequent plateau between ages 20 trough 50 (Heaton
et al., 1993). Since 29 participants in the present study were 18 and 19 years old (45.3
%) with the remaining participants ranging from 20 to 34 years old, age was used as a
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covariate in a 2 (dose) x 2 (group) analysis of covariance (ANCOVA) performed on
each individual dependent measure of WCST. The analysis showed very similar
results to those obtained with the original series of 2 x 2 ANOVAs indicating a
significant main effect of group on the measures of 'number of categories completed',
F (1, 55) =4.020, g=.050, and 'failure to maintain set' F (1, 55)=4.31, g=.043. The
statistical significance of the group effects was similarly not observed after the
ANCOVA was repeated following square root transformations of the raw scores on
the above measures, F (1, 55) =3.61, g=.062, for 'number of categories completed';
and F (1,55)=3.05, p=.086 for 'failure to maintain set'. Nevertheless, the analysis still
showed a significant group by dose interaction for 'learning to learn' with age used as
a covariate, F (1, 54)= 5.30, g=.025. A follow-up Tukey showed similar differences
between the placebo and nicotine conditions in the high attention and low attention
groups, but a greater separation of scores in the case of the latter group (M(placebo)=5.83, M(7mg nic) =-1.95) in comparison to the original ANOVA, indicating a greater
tendency towards improved learning of effective strategies following administration
of a 7mg nicotine patch in the low attention group.

CHAPTER IV

DISCUSSION
In partial support of the original hypothesis significant differences among the
groups following administration of nicotine were found primarily on measures of the
Conner's CPT. While no significant group differences were observed on any of the
measures of the Stroop task, nicotine seemed to have impaired performance of the
high attention group in the leaming-to-leam category of the WCST with no significant
treatment effects found in other categories of the test.
Conner's CPT
A square root transformation of the scores for the errors of commission on the
Conner's CPT showed that the participants in the nicotine groups committed
significantly fewer errors than those in the placebo groups, and revealed a pattern of
means, albeit non-significant, F (1, 59) = 2.61, p=.10, that indicated a trend towards
fewer errors of omission (M placebo =5.07 vs. M nicotine =1.94). Additionally, both
nicofine groups showed improvement in stimulus detectability (d') coupled with a
significantly fewer number of perseverations, thus providing partial support to the
initial hypothesis of attentional improvement following nicotine administration
especially on the measure of sustained attention, i.e. Conner's CPT.
Although the experimental hypothesis that nicotine treatment would also result
in faster response speeds especially in the low attention group was not supported by
the results, the findings are congruent with the recent research on transderamal
nicotine administration to non-smokers. Levin et al. (2000) found fewer errors of
omission on the Conner's CPT following administration of a 7mg nicotine patch to
78
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normal adult nonsmokers than in a placebo group. The researchers suggested that the
lower number of omissions was not due to a faster response rate that could have been
affected by nicotine, but due to improved accuracy, since a lower (albeit non
significant) rate for errors of commission was also observed. A significantly lower
rate of commission errors following a stabilizing data transformation was also
observed in the present study along with a non-significant trend towards fewer errors
of omission.
Comparing the performance of normal adult nonsmokers on the Conner's CPT
with that of ADHD adult nonsmokers, Levin et al. (2000) did not find a significant
reduction in CPT errors in the latter group but did find a significant reduction in
variability' of response speed over different blocks of the test session suggesting
improvement in attentional consistency. In a subsequent study Levin et al. (2001)
also found a robust nicotine-induced attenuation of the rise in CPT hit reaction time
standard error over blocks of the session, indicating reduction in response speed
variability. Lower numbers on this measure correspond to sustained or improved
response consistency as the test progressed (Levin et al., 2001).
Failure to detect an effect of nicotine on the measure of variability in the low
attention group in the present study could be partly due to the fact that Levin et al.
(2000, 2001) tested adult non-smokers diagnosed with ADHD, whereas in the present
study the low attention group consisted of individuals with lower scores on the
attention subscales of the Current Symptoms Scale by Barkley and Murphy (1998)
and Self-Report Rating Scale by McCamey and Anderson (1996). These scores were
not necessarily in the clinical range, since group assignment was performed on the
basis of only one low score on either measure. This difference is important as adults
in the present study shewing lower scores of attention might have functioned more
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like normal rather than clinical population since they did not differ on the variability
measure of the Conners CPT, a finding observed in adults without attentiuiial deficits
in the studies by Levin et al. (2000, 2001).
Stroop
The hypothesis predicted faster reaction times on the Stroop task in both
attention groups following administration of nicotine but with no significant effect of
treatment on the measure of interference (Stroop effect). Consistent with the previous
research (e.g. Levin et al., 1 996) the results demonstrated a robust Stroop effect for
both reaction time and accuracy rate but did not show any reduction in response
speeds across the conditions observed by Levin et al. (1996) following nicotine
administration. In their study Levin et al. (1996), however, did not find any significant
effect of nicotine on the Stroop effect itself, a finding that is similar to the research
evidence obtained in nicotine studies using smokers.
For example, no effect of nicotine on the Stroop effect was reported by Zack
et al. (2001) Similarly, no significant difference between the placebo and nicotine
conditions on the Stroop effect was reported by Mancuso et al. (1999) who treated
normal adult smokers with a 21 mg nicotine patches. Additionally, the researchers also
observed a significant effect of nicotine on reaction times indicating an overall
reduction in the speed of response. On the basis of these findings Mancuso et al.
(1999) proposed that nicotine enhanced non-selective attentional resources (sustained
attention) resulting in faster reaction times in both the control and interference
conditions. Nevertheless, since the researchers only tested chronic adult smokers and
did not screen for any attentional difficulties, it would be hard to say whether the
observed improvement in reaction time was due to acute administration of nicotine,
withdrawal effects evident in the placebo group, tolerance to nicotine in combination
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with its acute administration in the nicotine group, or due to the effects of nicotine in
individuals with high scores on attention measures.
In fact, in the present study not only was the reduction in reaction times not
observed, the relationship between nicotine administration and reaction times was
reversed. A non-significant trend was observed for dose, F (1, 57) = 3.106, p_=.08 on
reaction time measures indicating faster response speed in the placebo groups
(M=749.54 ms) than in the nicotine groups ( M = 857.74 ms). Since these results were
similar for all the groups irrespective of their attentional status, it could be, therefore,
suggested that acute administration of nicotine to non-smokers might interfere with
some aspects of cognitive functioning possibly due to the absence of nicotine
tolerance observed in chronic smokers. It is also possible that smokers exhibit greater
improvement in performance following nicotine treatment due to their sensitization to
nicotine, a situation that has been observed in animal studies investigating effects of
nicotine on memory (e.g. Grottick et al., 2000).
It is even possible that the selective aspect of attention, which is responsible
for filtering irrelevant information, might be reduced even in chronic smokers
providing them with fewer attentional resources. In a study by Ilan & Polich (2001)
P300 was measured in smokers who completed the Stroop task twice. Tire first group
of smokers was allowed to smoke two cigarettes after the first session of the task,
while the second group was given a similar non-smoking break. The researchers
obsei -d a significant decrease in P300 amplitude following a smoking break
although no significant differences between the groups were found on behavioral
measures of reaction time and accuracy. The researchers concluded that they did not
find support that tobacco smoking directly affected abstinent smokers' ability to
selectively attend to relevant stimulus attributes and disregard irrelevant attributes.
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The observed decrease in the P300 amplitude, however, could also be due to
increased automaticity of color naming, requiring less cognitive effort and thus
facilitating sustained rather than selective attention (Posner and Snyder, 1975).
Although sustained attention has been found to be enhanced in habitual
smokers following administration of nicotine (via smoking, transdermal patch or
injection) in almost all well-designed studies using RVIP (Levine et al., 2003), some
of the observed improvement in target detection could also be due to the amelioration
of cognitive deficits observed in abstinent smokers. A recent imaging study by
Lawrence et al. (2002) did show a significantly greater number of hits and faster
overall reaction times exhibited by smokers in the 21mg-of-nicotine condition on the
RVIP task when compared to abstinent smokers treated with a placebo patch. Since,
both groups, however, underwent two RVIP sessions with a counterbalanced nicotineplacebo administration (2.30 hours for patch application, 2 hour washout), the
significant findings were only observed when the placebo-nicotine order was used,
but not vice versa, suggesting possible practice effects as well and a circumscribed
time range of nicotine effectiveness after only 2 hours of patch application ( Mancuso
et al., 1999). A group of non-smokers was also used in the study but without any
nicotine treatment. This group did not differ from the placebo conditions in smokers
on any of the behavioral measures of the RVIP task. Similar comparison with the
nicotine conditions was not provided.
A somewhat different picture of differences between smokers and nonsmokers emerges after evaluating fMRI data obtained by Levine et al. (2002) during
the above RVIP task. Smokers in placebo conditions showed less task-induced
activation in the bilateral parietal cortex and bilateral caudate than non-smokers.
Smokers undergoing nicotine treatment, however, showed a significantly greater
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bilateral increase in activity in the parietal and occipital cortices, thalamus and
caudate, than abstinent smokers, irrespective of treatment order. The nicotine groups
also displayed further reduction in activity in regions that were deactivated during
task performance including the left insula.
On the basis of the findings Lawrence et al. (2002) suggested that nicotine
facilitated RVIP task performance in smokers by increasing activation in posterior
cortical and subcortical regions related to the visual attention and arousal aspects of
the task, rather than by activating frontal regions more involved in mediating
memory/target detection functions. Specifically, the researchers proposed that the
parietal cortex that receives converging signals from the ascending cholinergic and
noradrenergic pathways could mediate attention-enhancing effects of nicotine
observed ir. the RVIP task. Additionally, increased activation in the thalamus and
caudate suggests a general increase in arousal and motor activation. Although the
researchers proposed similar patterns of cortical and subcortical activation in nonsmokers treated with nicotine, such research still needs to be conducted. It is quite
possible that some of the regional cerbral blood flow (rCBF) differences observed in
smokers during RVIP could be due to hypoactivation of the corresponding brain
regions in abstinent smokers rather than to hyperactivation of these areas in the
nicotine condition. Since greater regional activations were observed in the group of
non-smoker., without nicotine treatment as compared to placebo smokers, a
hypothesis of similar hyperactivation patterns in non-smokers following nicotine
administration seems to be premature.
Despite mixed / insufficient evidence of the beneficial effects of nicotine in
non-smokers on measures of sustained (RVIP, CPT) and selective (Stroop) attention,
the Stroop task has previously shown sensitivity to attentional-executive functioning

84

in young adults with ADHD, who had displayed significant impairments in all three
conditions of the task in comparison with their age-matched peers without ADHD
(Seidman et al., 1997). It is, therefore, possible that in the present study the agonist
action of nicotine on cholinergic receptors implicated in attentional functioning was
masked and/or offset by its adverse autonomic effects (nausea, abdominal pain,
tachycardia, peripheral vasoconstriction, and elevated blood pressure) especially
prominent in individuals without any prior history of nicotine use (Prendergast et al.,
1997). In this respect other cholinergic agonists might be more appropriate for
therapeutic use than nicotine.
For example, Wilens et al. (1999) suggested using a synthetic compound
ABT-418, a selective alpha a4p2 cholonergic receptor agonist for the treatment of
adults with ADHD. Originally developed for the treatment of cognitive deterioration
in Alzheimer's disease, the agonist is available transdermally and has not been
associated with adverse side effects of nicotine (Prendergast et al., 1997). In their
study Wilens et al. (1999) reported a significantly greater proportion of nonsmokers
with ADHD displaying improvement of symptoms on the Clinical Global Impression
Scale (CGI) following transdermal administration (75mg/day) of ABT-418 for three
weeks, separated by 1 week of washout, than ADHD non-smokers in the placebo
group. Additionally, ABT-418 treated individuals reported a significantly greater
reduction of ADHD symptomatology on the DSM-IV ADHD symptom checklist. The
most robust improvement on this instrument was observed for the symptoms of
inattention.
Nevertheless, while ABT-418 may be a much safer compound than nicotine,
it may also bind less effectively than nicotine to alpha 7 receptors, which may explain
its inability to offer protracted effectiveness observed with nicotine on a delayed
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matching-to-sample task in aged monkeys (Prendergast et al., 1997). Levin (2002)
suggested that a7 nicotinic receptors in the hippocampus may be particularly
important for the expression of the actions of nicotine on working memory function
rather than attention.
At the same time recent evidence suggests that ct4p2 nicotinic cholinergic
receptors rather than a7 receptors might be essential for attentional processing (Ueno
et al., 2002). In a proposed animal model of ADHD Lleno et al. (2002b) demonstrated
that both nicotine and ABT-418 decreased spontaneous alternation behavior in
juvenile stroke-prone spontaneously hypertensive rats (SHRSP). SHRSP rats had been
previously shown to exhibit behavioral abnormalities such as inattention,
hyperactivity, and impulsivity similar to ADHD symptoms (Ueno et al., 2002a). The
alternation behavior was defined as a consecutive entry into three arms of a Y-maze,
i.e. the combination of three different arms, with stepwise combinations in the
sequence. The maximum number of alternations was thus the total number of arms
entered minus 2, and the percentage of alternation behavior was calculated as (actual
altemations/maximum alternations) x 100. The researchers concluded that since
nicotine had been previously reported to improve both selective and sustained
attention in rats via the activation of a4p2 receptors but not a l (Grottick et al., 2000),
selective a4p2 agonists such as ABT-418 may prove to be of great therapeutic value
in improving syrr itoms of inattentiveness in adults with ADHD particularly in cases
when lower side effect profiles are needed.
Finally, new genetic evidence suggests that individuals with the recently
isolated inattentive phenotype of ADHD could be most responsive to the therapeutic
use of alpha4 agonists such as ABT-418 (Todd et al., 2003). Tlius, ADHD
nonsmokers with pronounced attentional deficits exhibiting low tolerance to the
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adverse effects of nicotine might derive greater benefit from the use of other nicotinic
agonists such as ABT-418, which could prove more effective on the behavioral
measures of the Stroop task than its more toxic counterpart.
WCST
Consistent with the original hypothesis, administration of 7mg -of-nicotine
patches did not facilitate performance of the nicotine groups on any of the measures
of the WCST. On the contrary nicotine appeared to have impaired some aspects of
performance on this test. Specifically, nicotine-treated non-smokers in the high
attentiveness group exhibited lower conceptual efficiency across consecutive
categories of the WCST than their placebo counterparts as was evident from their
lower leaming-to-leam scores. An opposite trend, albeit non-significant, however,
was observed in the low attentiveness group that displayed better scores on that
measure following administration of nicotine that the placebo group. The leaming-toleam score is a measure that requires faculties beyond attention such as working
memory, and thus perhaps involves hippocampus to a greater extend than the previous
tasks (CPT and Stroop).
The role of the hippocampus in working memory has been well established in
animal research (Levin, 2002). Specifically, the importance ~f nicotine for working
memory on the level of hippocampus is most likely associated with its agonist action
at a4(32 and a7 receptor subtypes (Levin, 2000). Jones et al. (1992) reported that
many cholinergic drugs including nicotine can impair cognitive performance if too
large a dose of a drug is administered (an exceeded therapeutic window). Jones et al.
(1992) further suggested that observed cognitive impairments following large dose
administration of nicotine could be more apparent on measures of memory rather than
attention.
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Incidentally, Levin 12002) also reported that larger doses of cholinergic
antagonists infused in the hippocampus of rats following nicotine administration
resulted in less attenuation of nicotine-induced working- memory improvements than
with smaller doses due to lessened receptor specificity in the former case, thus again
suggesting a dose-related relationship between working memory functioning and
cholinergic action of nicotine.
Nevertheless, it appears that the noradrenergic activity of nicotine is perhaps
more prominent in ADHD, and specifically on tasks requiring working memory
functions. In a PET study by Mattay et al. (1996) demonstrated a significantly
decreased rCBF in the hippocampus and increased rCBF in the prefrontal cortex of
normal adults performing WCST following administration of d-amphetamine (dAMP). D-AMP, is a psychostimulant drug that produces an increase in the
spontaneous firing rate of hippocampal cells, which receive inhibitory input from the
locus ceruleus (LC) that gives rise to the dorsal noradrenergic bundle. In its turn, the
LC sends extensive NE projections to the prefrontal cortex, which is important in
mediating working memory and inhibition to irrelevant stimuli.
In a PET study of 25 adult subjects with ADHD Zametkin et al. (1990) found
reduced metabolism in the right hippocampus and prefrontal cortex in addition to
other regions. It's been suggested that the pathophysiology of ADHD involves an
'overdrive' of the LC with excessive release of NE leading to the reduced capacity of
the prefrontal cortex to respond to stimuli (Solanto, 1998). Thus, stimulants such as
nicotine can correct this abnormality by enhancing release of epinephrine in the
periphery, thereby inhibiting LC activity via sensory afferents (Solanto, 1998). If prior
to stimulant treatment ADHD patients exhibit decreased rCBF in the hippocampus
and the prefrontal cortex possibly due to excessive action of LC projections, then with
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nicotine administration a more optimized function of noradrenergic systems could
affect rCBF in the hippocampus and prefrontal cortex and facilitate working memory
functions required in WCST. Conversely, normal LC functioning in adults without
ADHD may be disrupted with an introduction of a psychostimulant drug that affects
noradrenergic systems leading to its increased inhibitory activity in the hippocampus,
and its hyper-excitatory action in the prefrontal cortex, which would entail decrements
in normal working memory functions.
Consequently, in our study the observed slight improvement on the leamingto-leam measure in the low attentiveness group following nicotine administration
could have been related to the noradrenergic activity of nicotine in the hippocampus
and prefrontal lobes. This improvement could have potentially reached statistical
significance, if the participants in that group had in fact been ADHD aduits with more
pronounced cognitive deficits. On the other hand, the observed impairment in the high
attentiveness group following nicotine administration could have resulted from acute
overactivation of the noradrenergic bundle.
Future Research Directions
The present study had a number of methodological shortcomings that can be
rectified in future research. The screening measures of attention used for the
assignment of individuals into low and high attention groups were not necessarily
accurate in representing individual attention deficits. These instruments were selfreport measures, which although standardized were not used in conjunction with other
neuropsychological tests to confirm attentional deficits. This could have left room for
misperception and/or misrepresentation of his attentional status by the respondent. A
stronger methodological approach would include a pilot study that would use the three
neuropsychological instruments (Conner's CPT, Stroop, and WCST) to make
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preliminary assessment of whether a randomly selected group of individuals with low
and high attention scores on the screening instruments show initial differences ill test
performance. In the present study such differences were not evident in placebo
conditions also suggesting that perhaps attention scores should be adjusted prior to the
assignment of individuals into their respective groups.
For example, to facilitate recruitment of individuals for their respective
groups, only one of the two measures was required to reflect either a high or a low
attention score, while the score on the other measure did not always correspond to the
criteria of a deficit or a superior faculty. Therefore, a better study would involve
individuals with attention scores that satisfy the selection criteria on both measures.
On the basis of the obtained findings it appears that the participants tested represented
two different ends of a bell curve of the normal population, notwithstanding the
significant differences between their baseline attention scores.
Furthermore, transdermal nicotine administration in 4 cases resulted in
participants' dismissal from the study due to adverse effects such as nausea, headache,
dizziness, and/or abdominal distress. Therefore, it is possible that the participants who
completed the study might not have been showing optimal functioning on cognitive
measures of attention and memory due to mild somatic or mood disturbances that
were not reported during the experiment. It would thus be appropriate to include a
measure of subjective physical and mood states (such as CGI) and to administer it
before and after the experiment.
To evaluate the extent of chronic effects of nicotine similarly attentionmatched groups of smokers could also be used, which would be helpful particularly
for the Stroop task. It is unfortunate, that in evaluating effects of nicotine on cognitive
functioning very few studies have used both normal smokers and non-smokers, and
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no studies to date have used ADHD and non-ADHD adults that represented both
smokers and non-smokers. Finally, transdermal nicotine effects could be directly
• J

juxtaposed with these of other less toxic stimulants such as ABT-418 on the same
measures of attention and subjective mood/body states. This approach could delineate
a more precise mechanism of nicotine action in ADHD adults with and without prior
history of nicotine use, and advance our quest for more effective therapies for this
pervasive and debilitating disorder.
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